Original Article
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
N Engl J Med 2004; 350:664-671February 12, 2004
- Abstract
Background
Insulin resistance appears to be the best predictor of the development of diabetes in the children of patients with type 2 diabetes, but the mechanism responsible is unknown.
Methods
We performed hyperinsulinemic–euglycemic clamp studies in combination with infusions of [6,6-2H2]glucose in healthy, young, lean, insulin-resistant offspring of patients with type 2 diabetes and insulin-sensitive control subjects matched for age, height, weight, and physical activity to assess the sensitivity of liver and muscle to insulin. Proton (1H) magnetic resonance spectroscopy studies were performed to measure intramyocellular lipid and intrahepatic triglyceride content. Rates of whole-body and subcutaneous fat lipolysis were assessed by measuring the rates of [2H5]glycerol turnover in combination with microdialysis measurements of glycerol release from subcutaneous fat. We performed 31P magnetic resonance spectroscopy studies to assess the rates of mitochondrial oxidative-phosphorylation activity in muscle.
Results
The insulin-stimulated rate of glucose uptake by muscle was approximately 60 percent lower in the insulin-resistant subjects than in the insulin-sensitive control subjects (P<0.001) and was associated with an increase of approximately 80 percent in the intramyocellular lipid content (P=0.005). This increase in intramyocellular lipid content was most likely attributable to mitochondrial dysfunction, as reflected by a reduction of approximately 30 percent in mitochondrial phosphorylation (P=0.01 for the comparison with controls), since there were no significant differences in systemic or localized rates of lipolysis or plasma concentrations of tumor necrosis factor α, interleukin-6, resistin, or adiponectin.
Conclusions
These data support the hypothesis that insulin resistance in the skeletal muscle of insulin-resistant offspring of patients with type 2 diabetes is associated with dysregulation of intramyocellular fatty acid metabolism, possibly because of an inherited defect in mitochondrial oxidative phosphorylation.
Media in This Article
Figure 1
Mean (±SE) Plasma Concentrations of Glucose (Panel A) and Insulin (Panel B) before and during an Oral Glucose-Tolerance Test in 9 Insulin-Sensitive Controls and 14 Insulin-Resistant Subjects.Figure 2
Insulin-Stimulated Rates of Muscle Glucose Metabolism (Panel A), Intramyocellular Lipid Content (Panel B), and Rates of Muscle Mitochondrial Phosphorylation Activity (Panel C) in Insulin-Sensitive Controls and Insulin-Resistant Subjects.Article Activity
- Article
Type 2 diabetes is rapidly becoming a worldwide epidemic.1 Although the primary cause of this disease is unknown, insulin resistance appears to have a major role, as evidenced by cross-sectional studies demonstrating insulin resistance in virtually all patients with type 2 diabetes, as well as prospective studies demonstrating the presence of insulin resistance one to two decades before the onset of the disease.2-4 In addition, insulin resistance in the offspring of patients with type 2 diabetes has been shown to be the best predictor of the development of the disease.5
Despite much work, little is known about the factors responsible for insulin resistance in persons at risk. In this regard, studies measuring triglyceride content of muscle-biopsy specimens6 or intramyocellular lipid content by means of proton (1H) magnetic resonance spectroscopy7-9 indicate a strong relation between intramuscular lipid content and insulin resistance in skeletal muscle. Studies have also identified increases in plasma fatty acid concentrations10 and intramyocellular lipid content8 in the insulin-resistant offspring of patients with type 2 diabetes, suggesting that dysregulation of fatty acid metabolism may mediate the insulin resistance in these persons. Increases in the intramyocellular concentration of fatty acid metabolites in turn have been postulated to activate a serine kinase cascade, which decreases the insulin-stimulated activity of insulin receptor substrate 1–associated phosphatidylinositol 3-kinase11-14 and results in reduced glucose transport12 and glycogen synthesis.15,16
In the present study we examined a potential mechanism for the intramyocellular accumulation of lipids in young, lean, insulin-resistant offspring of patients with type 2 diabetes. These subjects are ideal candidates for studies examining the earliest defects leading to insulin resistance, since in contrast to patients with diabetes, they are young, lean, healthy, and unlikely to have other confounding factors. Since increases in intramyocellular triglyceride content could occur as a result of the increased delivery of fatty acids from lipolysis, decreased rates of mitochondrial oxidative phosphorylation, or both, we examined these processes in the insulin-resistant offspring of patients with type 2 diabetes and in insulin-sensitive control subjects. We assessed rates of whole-body and subcutaneous fat lipolysis by measuring the rates of [2H5]glycerol turnover in combination with microdialysis measurements of the release of glycerol from subcutaneous fat. We determined the rates of in vivo mitochondrial phosphorylation and the ratio of inorganic phosphate to phosphocreatine in skeletal muscle using phosphorus-31 (31P) magnetic resonance spectroscopy. In addition, since studies have also implicated several adipocyte-derived hormones (tumor necrosis factor α,17 interleukin-6,18 resistin,19 and adiponectin20) in causing insulin resistance, we also measured plasma concentration of these factors in this group of insulin-resistant persons.
Methods
Subjects
All subjects were recruited by means of local advertising over a two-year period (2001 to 2003) and were prescreened to confirm that they were in excellent health, lean, nonsmoking, and taking no medications. A birth weight above 2.3 kg (5 lb) and a sedentary lifestyle, as defined by an activity index questionnaire,21 were also required. Qualifying subjects (more than 150 persons) underwent a three-hour oral glucose-tolerance test (with a 75-g oral glucose load), after which two subgroups of subjects were consecutively selected to identify extreme phenotypes for insulin resistance and increased insulin sensitivity.
Insulin-resistant subjects (3 men and 11 women) were defined as having an insulin sensitivity index22 of less than 4.0 (indicating insulin resistance; lower values indicate greater insulin resistance), at least one parent or grandparent with type 2 diabetes, and at least one other family member with type 2 diabetes. Insulin-sensitive control subjects (five men and seven women) were defined by an insulin sensitivity index of greater than 6.3 (with or without a family history of type 2 diabetes).
All qualifying subjects subsequently underwent a complete medical history taking and a physical examination along with blood tests to verify that the following were normal: blood and platelet counts; concentrations of electrolytes, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, creatinine, cholesterol, and triglycerides; prothrombin time; and partial-thromboplastin time. In addition, subjects underwent 1H magnetic resonance spectroscopy studies to determine the triglyceride content of liver and muscle. The subjects then underwent a hyperinsulinemic–euglycemic clamp study to assess the responsiveness of liver, muscle, and fat to insulin or 31P magnetic resonance spectroscopy studies to assess the rates of muscle mitochondrial phosphorylation and the ratio of inorganic phosphate to phosphocreatine. Owing to the complexity of the protocol, not all the subjects were able to complete both the magnetic resonance spectroscopy and clamp studies. Two of the 12 control subjects, who initially qualified on the basis of their insulin sensitivity index, were subsequently excluded after the hyperinsulinemic–euglycemic clamp study identified them as insulin resistant, whereas all subjects who were found to be insulin resistant on the basis of the insulin sensitivity index were also found to be insulin resistant on the basis of the clamp study.
Written consent was obtained from each subject after the purpose, nature, and potential complications of the studies had been explained. The protocol was approved by the human-investigation committee of Yale University.
Diet and Study Preparation
The subjects were instructed to eat a regular, weight-maintenance diet containing at least 150 g of carbohydrate per day for three days before admission for either the clamp or magnetic resonance spectroscopy study. All subjects were instructed not to perform any exercise other than normal walking for the three days before the study. To minimize changes in glucose metabolism resulting from ovarian hormonal effects, the female subjects were studied during the follicular phase (days 0 through 12) of the menstrual cycle.23 Subjects were admitted to the Yale–New Haven Hospital General Clinical Research Center the evening before the clamp or 31P magnetic resonance spectroscopy study, and the subjects continued to fast while having free access to regular drinking water until the completion of the study the following day.
Measurement of Metabolites and Hormones
Plasma glucose concentrations were measured with the use of a YSI 2700 STAT Analyzer (Yellow Springs Instruments). Plasma concentrations of insulin, glucagon, adiponectin, and resistin were measured with the use of double-antibody radioimmunoassay kits (Linco). Plasma tumor necrosis factor α and interleukin-6 were measured with the use of Quantine High Sensitivity kits (R&D Systems). Plasma fatty acid concentrations were determined with the use of a microfluorometric method.24 Urine nitrogen content was measured at the Mayo Medical Laboratories (Rochester, Minn.). Microdialysate glycerol concentrations (in 0.5-μl samples) were measured with the use of enzyme-linked colorimetry by a CMA 600 microdialysis analyzer (Microdialysis).25 Ethanol concentrations were determined enzymatically with the use of a YSI 2700 STAT Analyzer.25 Gas chromatography–mass spectrometry analyses of the enrichment of [6,6-2H2]glucose and [2H5]glycerol in plasma were performed with the use of a Hewlett–Packard Mass Selective Detector (model 5971A) as previously described.25
Magnetic Resonance Spectroscopy of Intramyocellular and Intrahepatic Triglyceride Content
On a separate day, after a 12-hour fast, all subjects were transported by wheelchair to the Yale Magnetic Resonance Center, and localized 1H magnetic resonance spectroscopy spectra of the soleus muscle and liver were acquired on a 2.1-T Biospec Spectrometer (Bruker Instruments) as previously described.25
Hyperinsulinemic–Euglycemic Clamp Studies
Basal rates of glucose and glycerol turnover were assessed during a three-hour basal period and insulin-stimulated rates were assessed with a three-hour hyperinsulinemic–euglycemic clamp with the use of 20 mU of insulin per square meter of body-surface area per minute, [6,6-2H2]glucose, and [2H5]glycerol as previously described.26 Rates of whole-body energy expenditure and glucose and fat oxidation were assessed by indirect calorimetry (Deltratrack Metabolic Monitor, Sensormedics) during the last 30 minutes of the 3-hour base-line period and during the last 30 minutes of the clamp period.27 Localized rates of in vivo lipolysis were assessed before and during the clamp procedure with the use of microdialysis probes (CMA/60, CMA, Microdialysis) inserted into the fat deposits in two locations on the abdomen, 4 to 6 cm below the umbilicus, as previously described.25
Magnetic Resonance Spectroscopy of Mitochondrial Phosphorylation
Rates of mitochondrial phosphorylation were assessed by 31P magnetic resonance spectroscopy saturation transfer performed at 36.31 MHz with the use of a flat, concentric probe made of an inner coil 9 cm in diameter (for 31P) and a 13-cm outer coil tuned to proton frequency for scout imaging and shimming as previously described.28 Unidirectional rates of ATP synthesis were measured with the use of the saturation-transfer method applied to the exchange between inorganic phosphate and ATP. The steady-state magnetization of inorganic phosphate was measured in the presence of a selective irradiation of the γ resonance of ATP and compared with the magnetization of inorganic phosphate at equilibrium in a control spectrum (without irradiation of the γ resonance of ATP).28 The total acquisition time for 31P magnetic resonance spectra was about 120 minutes. The ratio of inorganic phosphate to phosphocreatine in the soleus muscle was measured by 31P magnetic resonance spectroscopy as previously described.29,30
Statistical Analysis
Statistical analyses were performed with StatView software (Abacus Concepts). To detect statistically significant differences between control subjects and insulin-resistant subjects, we used unpaired Student's t-tests for independent samples, with a two-sided P value of less than 0.05 considered to indicate statistical significance. Non-normally distributed data (i.e., data regarding the area under the curve) were logarithmically transformed. All data are expressed as means ±SE in the text.
Results
Characteristics of the Subjects
Insulin-sensitive control subjects and insulin-resistant subjects were frequency matched for age, weight, height, body-mass index, and activity index and had similar fasting plasma concentrations of glycosylated hemoglobin, adiponectin, tumor necrosis factor α, interleukin-6, and resistin (Table 1Table 1
Characteristics of the Two Groups of Subjects.). In contrast, the insulin sensitivity index was markedly lower in the insulin-resistant subjects than in the insulin-sensitive control subjects (mean [±SE], 2.8±0.2 vs. 10.2±1.4; P<0.001).Oral Glucose-Tolerance Test
All subjects had normal glucose-tolerance tests, but the plasma concentrations of glucose (Figure 1AFigure 1
Mean (±SE) Plasma Concentrations of Glucose (Panel A) and Insulin (Panel B) before and during an Oral Glucose-Tolerance Test in 9 Insulin-Sensitive Controls and 14 Insulin-Resistant Subjects.) and insulin (Figure 1B) before and during the test were significantly higher in the insulin-resistant subjects. Fasting plasma fatty acid concentrations were similar in the insulin-sensitive control subjects (0.37±0.05 mM) and the insulin-resistant subjects (0.47±0.05 mM, P=0.17) and decreased by approximately 80 percent in both groups during the glucose-tolerance test. There were no significant differences in the fasting plasma glucagon concentrations between the insulin-sensitive control subjects (56±4 pg per milliliter) and the insulin-resistant subjects (59±3 pg per milliliter, P=0.64).Hyperinsulinemic–Euglycemic Clamp Studies
Fasting rates of glucose production were similar in the nine insulin-sensitive control subjects (2.3±0.1 mg per kilogram of body weight per minute) and the eight insulin-resistant subjects (2.0±0.3 mg per kilogram per minute, P=0.41) for whom results were available and were completely suppressed in both groups during the period of hyperinsulinemic–euglycemic clamping. In contrast, the rates of glucose infusion required to maintain euglycemia were approximately 60 percent lower in the insulin-resistant subjects than in the insulin-sensitive control subjects during clamping (3.3±0.3 mg per kilogram per minute vs. 7.7±0.5 mg per kilogram per minute, P<0.001) and the insulin-stimulated rates of peripheral glucose uptake were also approximately 60 percent lower in the insulin-resistant group (P<0.001) (Figure 2AFigure 2
Insulin-Stimulated Rates of Muscle Glucose Metabolism (Panel A), Intramyocellular Lipid Content (Panel B), and Rates of Muscle Mitochondrial Phosphorylation Activity (Panel C) in Insulin-Sensitive Controls and Insulin-Resistant Subjects.). This reduction in peripheral glucose metabolism could be attributed mostly to a reduction of approximately 70 percent (P<0.001) in nonoxidative glucose disposal in the insulin-resistant subjects (data not shown). There were no significant differences in fasting or insulin-stimulated rates of whole-body glucose or fat oxidation between the two groups (data not shown). Fasting rates of whole-body energy expenditure tended to be lower in the insulin-resistant group than in the control group (21.8±0.7 kcal per kilogram per 24 hours vs. 24.6±1.1 kcal per kilogram per 24 hours, P=0.06), and the same was true for insulin-stimulated rates (21.6±0.9 kcal per kilogram per 24 hours and 24.9±0.7 kcal per kilogram per 24 hours, respectively; P=0.01).Whole-Body and Localized Rates of Glycerol Metabolism
Fasting rates of glycerol turnover were similar in the control group and the insulin-resistant group (0.21±0.03 μmol per minute and 0.18±0.02 μmol per minute, respectively; P=0.32), as was the insulin-induced suppression of glycerol turnover during the clamp study (0.11±0.01 μmol per minute and 0.09±0.01 μmol per minute, respectively; P=0.64). Consistent with this finding, the interstitial glycerol concentration, as assessed by microdialysis, decreased by a similar degree in the insulin-sensitive control subjects (36±7 percent) and the insulin-resistant subjects (41±6 percent, P=0.67) during the hyperinsulinemic–euglycemic clamp study.
Intramyocellular and Intrahepatic Triglyceride Content
The intramyocellular lipid content in the soleus muscle was approximately 80 percent higher (P=0.005) in the 12 insulin-resistant offspring in whom it was measured than in the 10 insulin-sensitive control subjects in whom it was measured (Figure 2B). There was no significant difference with respect to intrahepatic triglyceride content between insulin-resistant subjects (2.35±1.49 percent) and insulin-sensitive control subjects (0.47±0.16 percent, P=0.29).
Rates of Mitochondrial Phosphorylation and Ratio of Inorganic Phosphate to Phosphocreatine
Rates of mitochondrial phosphorylation in skeletal muscle were approximately 30 percent lower (P=0.01) in the 13 insulin-resistant subjects in whom it was evaluated than in the 10 control subjects in whom it was evaluated (Figure 2C). The ratio of inorganic phosphate to phosphocreatine in the soleus muscle was reduced by approximately 20 percent (P=0.002) in the insulin-resistant subjects (0.113±0.004), as compared with the control subjects (0.137±0.005).
Discussion
The lean, insulin-resistant offspring of patients with type 2 diabetes had severe insulin resistance, as compared with insulin-sensitive control subjects matched for age, height, weight, and activity. The difference could be attributed largely to a reduction of approximately 70 percent in insulin-stimulated nonoxidative muscle glucose metabolism. Using 1H magnetic resonance spectroscopy to measure intramyocellular lipid content, we found that insulin resistance in muscle was accompanied by an increase of approximately 80 percent in intramyocellular lipid content in the insulin-resistant subjects, as compared with the insulin-sensitive control subjects. These data are consistent with those of previous studies in humans7-9 and rodents,31,32 which have suggested that dysregulated intramuscular fatty acid metabolism has an important causative role in insulin resistance and may have a similar role in fat-induced insulin resistance in the skeletal muscle of the insulin-resistant offspring of patients with type 2 diabetes.
To assess whether the increase in intramyocellular lipid content in the insulin-resistant subjects was due to increased delivery of fatty acids to the muscle, we measured whole-body and localized rates of lipolysis. Rates of whole-body lipolysis were similar in the control subjects and the insulin-resistant subjects during the basal state and were both suppressed to a similar degree during the hyperinsulinemic–euglycemic clamp study. In a manner consistent with this finding, we found that the extent of insulin-induced suppression of the localized rates of lipolysis in subcutaneous fat, as assessed by microdialysis, was also similar in both groups. Taken together, these data suggest that insulin resistance was confined largely to skeletal muscle and that increased basal rates of peripheral lipolysis and defects in insulin-induced suppression of lipolysis do not have a major role in causing the increased intramyocellular lipid content in the insulin-resistant subjects.
To assess whether decreased mitochondrial activity may contribute to the increased intramyocellular lipid content, we also assessed the rates of muscle mitochondrial phosphorylation using 31P magnetic resonance spectroscopy. We found that the mitochondrial rates of ATP production were reduced by approximately 30 percent in the muscle of the insulin-resistant subjects, as compared with the insulin-sensitive control subjects. Consistent with this finding of altered mitochondrial function, we also found a reduced ratio of inorganic phosphate to phosphocreatine, which may reflect a lower ratio of type I fibers (mostly oxidative) to type II fibers (mostly glycolytic) in the insulin-resistant subjects.29,30 This finding is consistent with those of a biopsy study by Nyholm et al., who found an increased number of type IIb muscle fibers in overweight, insulin-resistant, first-degree relatives of patients with type 2 diabetes.33 Taken together, these data suggest that the insulin-resistant offspring of patients with type 2 diabetes have an inherited reduction in mitochondrial content in muscle, which in turn may be responsible for the reduced rates of mitochondrial oxidative phosphorylation.
Several studies have also implicated a number of novel adipocyte-derived factors in mediating insulin resistance in patients with obesity and in those with type 2 diabetes.17,18,34-37 To address the potential role of resistin, tumor necrosis factor α, interleukin-6, and adiponectin in mediating insulin resistance in our insulin-resistant subjects, we measured the plasma concentrations of these factors and found no significant differences between the two groups. These data suggest that alterations in plasma concentrations of these adipocyte-derived factors do not have a major role in mediating insulin resistance in these persons.
Taken together, our results support the hypothesis that insulin resistance in these young people is due to dysregulation of intramyocellular fatty acid metabolism, which may be caused by an inherited defect in mitochondrial oxidative phosphorylation. Such a defect might be due to a reduction in mitochondrial content, which in turn might be attributable to a reduced ratio of type I to type II muscle fibers. These results are similar to those in lean, elderly, insulin-resistant subjects, whose insulin resistance, in contrast to that in insulin-resistant offspring, is most likely attributable to acquired defects in mitochondrial biogenesis, which lead to reductions in skeletal-muscle mitochondrial content.38 Furthermore, since mitochondria have a critical role in mediating glucose-induced insulin secretion,39 the presence of similar inherited defects in beta-cell mitochondrial function or content, in the setting of peripheral insulin resistance, might explain the increased incidence of diabetes in the insulin-resistant offspring of patients with type 2 diabetes.5 These data also identify mitochondrial oxidative phosphorylation as a potential target for the prevention and treatment of type 2 diabetes.
In this regard it is of interest that a common Gly482Ser polymorphism of the peroxisome-proliferator–activated receptor γ coactivator 1, a transcriptional regulator of genes responsible for mitochondrial biogenesis and fat oxidation,40 has been linked to an increased relative risk of type 2 diabetes in Danish populations41 as well as to altered lipid oxidation and insulin secretion in Pima Indians.42 In addition, two recent studies involving DNA-microarray analysis suggest that there is a coordinated reduction in the expression of genes encoding peroxisome-proliferator–activated receptor γ coactivator 1α, which are involved in oxidative phosphorylation, in the skeletal muscle of overweight patients with type 2 diabetes,43 obese Mexican-American patients with type 2 diabetes,44 and overweight nondiabetic subjects with a family history of diabetes.44
Supported by grants (K23 DK-02347, R01 AG-23686, R01 DK-063192, R01 DK-49230, P30 DK-45735, and M01 RR-00125) from the Public Health Service and the Yamanouchi USA Foundation.
We are indebted to Drs. Michael Lehrke and Mitch Lazar for assistance in measuring plasma resistin concentrations; to Dr. James Dziura for statistical assistance; to Yanna Kosover, Mikhail Smolgovsky, Anthony Romanelli, Aida Groszmann, Andrea Belous, Jonas Lai, Sandra Alfano, and the staff of the Yale–New Haven Hospital General Clinical Research Center for expert technical assistance with the studies; and to the volunteers for participating in this study.
Source Information
From the Departments of Internal Medicine (K.F.P., D.B., R.G., G.I.S.) and Cellular and Molecular Physiology (G.I.S.) and the Howard Hughes Medical Institute (S.D., G.I.S.), Yale University School of Medicine, New Haven, Conn.
Address reprint requests to Dr. Shulman at the Howard Hughes Medical Institute, Box 208020, Yale University School of Medicine, 300 Cedar St., S269 CAB, New Haven, CT 06510, or at gerald.shulman@yale.edu.
- References
References
1
Zimmet P ,Alberti KG ,Shaw J . Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787
CrossRef | Web of Science | Medline2
Lillioja S ,Mott DM ,Howard BV , et al. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1988;318:1217-1225
Full Text | Web of Science | Medline3
Lillioja S ,Mott DM ,Spraul M , et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 1993;329:1988-1992
Full Text | Web of Science | Medline4
DeFronzo RA ,Bonadonna RC ,Ferrannini E . Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992;15:318-368
CrossRef | Web of Science | Medline5
Warram JH ,Martin BC ,Krolewski AS ,Soeldner JS ,Kahn CR . Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Ann Intern Med 1990;113:909-915
Web of Science | Medline6
Phillips DI ,Caddy S ,Ilic V , et al. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996;45:947-950
CrossRef | Web of Science | Medline7
Krssak M ,Falk Petersen K ,Dresner A , et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-116[Erratum, Diabetologia 1999;42:386, 1269.]
CrossRef | Web of Science | Medline8
Perseghin G ,Scifo P ,De Cobelli F , et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-1606
CrossRef | Web of Science | Medline9
Szczepaniak LS ,Babcock EE ,Schick F , et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999;276:E977-E989
Web of Science | Medline10
Perseghin G ,Ghosh S ,Gerow K ,Shulman GI . Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 1997;46:1001-1009
CrossRef | Web of Science | Medline11
Griffin ME ,Marcucci MJ ,Cline GW , et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999;48:1270-1274
CrossRef | Web of Science | Medline12
Dresner A ,Laurent D ,Marcucci M , et al. Effect of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999;103:253-259
CrossRef | Web of Science | Medline13
Yu C ,Chen Y ,Cline GW , et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002;277:50230-50236
CrossRef | Web of Science | Medline14
Itani SI ,Ruderman NB ,Schmieder F ,Boden G . Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002;51:2005-2011
CrossRef | Web of Science | Medline15
Boden G ,Chen X ,Ruiz J ,White JV ,Rossetti L . Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-2446
CrossRef | Web of Science | Medline16
Roden M ,Price TB ,Perseghin G , et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97:2859-2865
CrossRef | Web of Science | Medline17
Hotamisligil GS ,Shargill NS ,Spiegelman BM . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91
CrossRef | Web of Science | Medline18
Kern PA ,Ranganathan S ,Li C ,Wood L ,Ranganathan G . Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745-E751
Web of Science | Medline19
Steppan CM ,Bailey ST ,Bhat S , et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312
CrossRef | Web of Science | Medline20
Yamauchi T ,Kamon J ,Waki H , et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946
CrossRef | Web of Science | Medline21
Baecke JA ,Burema J ,Frijters JE . A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-942
Web of Science | Medline22
Matsuda M ,DeFronzo RA . Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470
CrossRef | Web of Science | Medline23
Diamond MP ,Jacob R ,Connolly-Diamond M ,DeFronzo RA . Glucose metabolism during the menstrual cycle: assessment with the euglycemic, hyperinsulinemic clamp. J Reprod Med 1993;38:417-421
Web of Science | Medline24
Miles J ,Glasscock R ,Aikens J ,Gerich J ,Haymond M . A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 1983;24:96-99
Web of Science | Medline25
Mayerson AB ,Hundal RS ,Dufour S , et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 2002;51:797-802
CrossRef | Web of Science | Medline26
Maggs DG ,Buchanan TA ,Burant CF , et al. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998;128:176-185
Web of Science | Medline27
Petersen KF ,Hendler R ,Price T , et al. 13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes 1998;47:381-386
CrossRef | Web of Science | Medline28
Lebon V ,Dufour S ,Petersen KF , et al. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest 2001;108:733-737
Web of Science | Medline29
Meyer RA ,Brown TR ,Kushmerick MJ . Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle. Am J Physiol 1985;248:C279-C287
Web of Science | Medline30
Vandenborne K ,Walter G ,Ploutz-Snyder L , et al. Energy-rich phosphates in slow and fast human skeletal muscle. Am J Physiol 1995;268:C869-C876
Web of Science | Medline31
Kraegen EW ,Clark PW ,Jenkins AB ,Daley EA ,Chisholm DJ ,Storlien LH . Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991;40:1397-1403
CrossRef | Web of Science | Medline32
Kim JK ,Fillmore JJ ,Chen Y , et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 2001;98:7522-7527
CrossRef | Web of Science | Medline33
Nyholm B ,Qu Z ,Kaal A , et al. Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 1997;46:1822-1828
CrossRef | Web of Science | Medline34
Steppan CM ,Lazar MA . Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002;13:18-23
CrossRef | Web of Science | Medline35
Tsao TS ,Lodish HF ,Fruebis J . ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 2002;440:213-221
CrossRef | Web of Science | Medline36
Pajvani UB ,Scherer PE . Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep 2003;3:207-213
CrossRef | Medline37
Yamauchi T ,Kamon J ,Minokoshi Y , et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-1295
CrossRef | Web of Science | Medline38
Petersen KF ,Befroy D ,Dufour S , et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-1142
CrossRef | Web of Science | Medline39
Luft R ,Luthman H . Mitokondriernas patofysiologi: från Lufts sjukdom till åldrande och diabetes. Lakartidningen 1993;90:2770-2775
Medline40
Wu Z ,Puigserver P ,Andersson U , et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999;98:115-124
CrossRef | Web of Science | Medline41
Ek J ,Andersen G ,Urhammer SA , et al. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 2001;44:2220-2226
CrossRef | Web of Science | Medline42
Muller YL ,Bogardus C ,Pedersen O ,Baier L . A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 2003;52:895-898
CrossRef | Web of Science | Medline43
Mootha VK ,Lindgren CM ,Eriksson KF , et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-273
CrossRef | Web of Science | Medline44
Patti ME ,Butte AJ ,Crunkhorn S , et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003;100:8466-8471
CrossRef | Web of Science | Medline
- Citing Articles (454)
Citing Articles
1
S. K. Hutchison, H. J. Teede, D. Rachoń, C. L. Harrison, B. J. Strauss, N. K. Stepto. (2012) Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome. Diabetologia
CrossRef2
Kristy D.M. Wittmeier, Brandy A. Wicklow, Andrea C. MacIntosh, Elizabeth A.C. Sellers, Lawrence N. Ryner, Hacene Serrai, Philip F. Gardiner, Heather J. Dean, Jonathan M. McGavock. (2012) Hepatic Steatosis and Low Cardiorespiratory Fitness in Youth With Type 2 Diabetes. Obesity
CrossRef3
Jaechan Leem, Eun Hee Koh. (2012) Interaction between Mitochondria and the Endoplasmic Reticulum: Implications for the Pathogenesis of Type 2 Diabetes Mellitus. Experimental Diabetes Research 2012, 1-8
CrossRef4
Mi-Young Kim, Jin-Sik Bae, Tae-Hyun Kim, Joo-Man Park, Yong Ho Ahn. (2012) Role of Transcription Factor Modifications in the Pathogenesis of Insulin Resistance. Experimental Diabetes Research 2012, 1-16
CrossRef5
Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Alastair D. Burt. 2012. Fatty liver disease. , 293-359.
CrossRef6
Małgorzata Marjańska, Lynn E. Eberly, Gregor Adriany, Sarah N. Verdoliva, Michael Garwood, Lisa Chow. (2012) Influence of foot orientation on the appearance and quantification of 1H magnetic resonance muscle spectra obtained from the soleus and the vastus lateralis. Magnetic Resonance in Medicinen/a-n/a
CrossRef7
Stephen H. Caldwell, Curtis K. Argo, Abdullah M. S. Al-Osaimi. 2011. Nonalcoholic Fatty Liver Disease. , 868-907.
CrossRef8
Gislaine T. Rezin, Isabela C. Jeremias, Gabriela K. Ferreira, Mariane R. Cardoso, Meline O.S. Morais, Lara M. Gomes, Otaviana B. Martinello, Samira S. Valvassori, João Quevedo, Emilio L. Streck. (2011) Brain energy metabolism is activated after acute and chronic administration of fenproporex in young rats. International Journal of Developmental Neuroscience 29:8, 937-942
CrossRef9
Sang-Hee Lee, Da-Jung Chung, Hee-Sun Lee, Tae-June Kim, Myung-Hee Kim, Hyeon Jeong Jeong, Jee-Aee Im, Duk-Chul Lee, Ji-Won Lee. (2011) Mitochondrial DNA copy number in peripheral blood in polycystic ovary syndrome. Metabolism 60:12, 1677-1682
CrossRef10
André C Carpentier, Sébastien M Labbé, Thomas Grenier-Larouche, Christophe Noll. (2011) Abnormal dietary fatty acid metabolic partitioning in insulin resistance and Type 2 diabetes. Clinical Lipidology 6:6, 703-716
CrossRef11
Nishanth E. Sunny, Elizabeth J. Parks, Jeffrey D. Browning, Shawn C. Burgess. (2011) Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease. Cell Metabolism 14:6, 804-810
CrossRef12
Juan Zheng, Lu-Lu Chen, Hao-Hao Zhang, Xiang Hu, Wen Kong, Di Hu. (2011) Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle. Metabolism
CrossRef13
Jean-Louis Gallis, Nizar Serhan, Henri Gin, Patrice Couzigou, Marie-Christine Beauvieux. (2011) Resveratrol plus ethanol counteract the ethanol-induced impairment of energy metabolism: 31P NMR study of ATP and sn-glycerol-3-phosphate on isolated and perfused rat liver. Pharmacological Research
CrossRef14
Chin-Yuan Hsu, Yu-Pei Chan. (2011) The use of honeybees reared in a thermostatic chamber for aging studies. AGE
CrossRef15
Aline Pertile Remor, Filipe José de Matos, Karina Ghisoni, Thiago Lenoir da Silva, Greici Eidt, Marília Búrigo, Andreza Fabro de Bem, Paulo César Lock Silveira, Andrés de León, Maria Cecilia Sanchez, Alexandre Hohl, Viviane Glaser, Carlos-Alberto Gonçalves, André Quincozes-Santos, Rafael Borba Rosa, Alexandra Latini. (2011) Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: Involvement of advanced glycosylated end products. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:11, 1460-1471
CrossRef16
Zhong Q. Wang, Xian H. Zhang, Yongmei Yu, Alexander. Poulev, David Ribnicky, Z. Elizabeth Floyd, William T. Cefalu. (2011) Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice. The Journal of Nutritional Biochemistry 22:11, 1064-1073
CrossRef17
Hubert Kolb, Décio L. Eizirik. (2011) Resistance to type 2 diabetes mellitus: a matter of hormesis?. Nature Reviews Endocrinology
CrossRef18
MELANIE S. HOOD, JONATHAN P. LITTLE, MARK A. TARNOPOLSKY, FRANK MYSLIK, MARTIN J. GIBALA. (2011) Low-Volume Interval Training Improves Muscle Oxidative Capacity in Sedentary Adults. Medicine & Science in Sports & Exercise 43:10, 1849-1856
CrossRef19
A. H. Olsson, B. T. Yang, E. Hall, J. Taneera, A. Salehi, M. Dekker Nitert, C. Ling. (2011) Decreased expression of genes involved in oxidative phosphorylation in human pancreatic islets from patients with type 2 diabetes. European Journal of Endocrinology 165:4, 589-595
CrossRef20
Matthew D. Hirschey, Tadahiro Shimazu, Enxuan Jing, Carrie A. Grueter, Amy M. Collins, Bradley Aouizerat, Alena Stančáková, Eric Goetzman, Maggie M. Lam, Bjoern Schwer, Robert D. Stevens, Michael J. Muehlbauer, Sanjay Kakar, Nathan M. Bass, Johanna Kuusisto, Markku Laakso, Frederick W. Alt, Christopher B. Newgard, Robert V. Farese, C. Ronald Kahn, Eric Verdin. (2011) SIRT3 Deficiency and Mitochondrial Protein Hyperacetylation Accelerate the Development of the Metabolic Syndrome. Molecular Cell 44:2, 177-190
CrossRef21
Abdulmaged M. Traish, Bassima Abdallah, George Yu. (2011) Androgen deficiency and mitochondrial dysfunction: implications for fatigue, muscle dysfunction, insulin resistance, diabetes, and cardiovascular disease. Hormone Molecular Biology and Clinical Investigation 8:1, 431-444
CrossRef22
Michael E. Widlansky, David D. Gutterman. (2011) Regulation of Endothelial Function by Mitochondrial Reactive Oxygen Species. Antioxidants & Redox Signaling 15:6, 1517-1530
CrossRef23
Julia Szendroedi, Esther Phielix, Michael Roden. (2011) The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nature Reviews Endocrinology
CrossRef24
John C. Clapham, Jonathan R.S. Arch. (2011) Targeting thermogenesis and related pathways in anti-obesity drug discovery. Pharmacology & Therapeutics 131:3, 295-308
CrossRef25
Kristin Eckardt, Annika Taube, Juergen Eckel. (2011) Obesity-associated insulin resistance in skeletal muscle: Role of lipid accumulation and physical inactivity. Reviews in Endocrine and Metabolic Disorders 12:3, 163-172
CrossRef26
Takashi Yokota, Shintaro Kinugawa, Koichi Okita, Kagami Hirabayashi, Tadashi Suga, Masaaki Hattori, Yoshinao Nakagawa, Noriko Oyama-Manabe, Hiroki Shirato, Hiroyuki Tsutsui. (2011) Lower aerobic capacity was associated with abnormal intramuscular energetics in patients with metabolic syndrome. Hypertension Research 34:9, 1029-1034
CrossRef27
Donal J. O'Gorman, Anna Krook. (2011) Exercise and the Treatment of Diabetes and Obesity. Medical Clinics of North America 95:5, 953-969
CrossRef28
Valentin Barquissau, Béatrice Morio. (2011) Physiopathologie de l’insulinorésistance dans le muscle squelettique et implication des fonctions mitochondriales. Nutrition Clinique et Métabolisme 25:3, 114-130
CrossRef29
Jisu Oh, Soo-Kyung Kim, Dae-Kyu Shin, Kyung-Sun Park, Seok Won Park, Yong-Wook Cho. (2011) A Simple Ultrasound Correlate of Visceral Fat. Ultrasound in Medicine & Biology 37:9, 1444-1451
CrossRef30
Julia Szendroedi, Esther Phielix, Michael Roden. 2011. Assessment of Insulin Sensitivity. , 88-105.
CrossRef31
L. Pham, L. Christadore, S. Schaus, E. D. Kolaczyk. (2011) Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis. Proceedings of the National Academy of Sciences 108:32, 13347-13352
CrossRef32
Taina Koponen, Marc Cerrada-Gimenez, Eija Pirinen, Esa Hohtola, Jussi Paananen, Susanna Vuohelainen, Maija Tusa, Sini Pirnes-Karhu, Sami Heikkinen, Antti Virkamäki, Anne Uimari, Leena Alhonen, Markku Laakso. (2011) The activation of hepatic and muscle polyamine catabolism improves glucose homeostasis. Amino Acids
CrossRef33
Wei Yang, Lisa de las Fuentes, Victor G Dávila-Román, C Charles Gu. (2011) Variable set enrichment analysis in genome-wide association studies. European Journal of Human Genetics 19:8, 893-900
CrossRef34
Ee L. Lim, Kieren G. Hollingsworth, Fiona E. Smith, Peter E. Thelwall, Roy Taylor. (2011) Inhibition of lipolysis in Type 2 diabetes normalizes glucose disposal without change in muscle glycogen synthesis rates. Clinical Science 121:4, 169-177
CrossRef35
Aurawan Vongs, Kelli J. Solly, Laszlo Kiss, Douglas J. MacNeil, Charles I. Rosenblum. (2011) A Miniaturized Homogenous Assay of Mitochondrial Membrane Potential. ASSAY and Drug Development Technologies 9:4, 373-381
CrossRef36
Sameer S. Kulkarni, Firoozeh Salehzadeh, Tomas Fritz, Juleen R. Zierath, Anna Krook, Megan E. Osler. (2011) Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus. Metabolism
CrossRef37
Jennifer G. Duncan. (2011) Mitochondrial dysfunction in diabetic cardiomyopathy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:7, 1351-1359
CrossRef38
Pablo M. Garcia-Roves. (2011) RETRACTED: Mitochondrial pathophysiology and type 2 diabetes mellitus. Archives Of Physiology And Biochemistry 117:3, 177-187
CrossRef39
Da Young Oh, William S Lagakos. (2011) The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity. Current Opinion in Clinical Nutrition and Metabolic Care 14:4, 322-327
CrossRef40
Anders H. Olsson, Tina Rönn, Tarq Elgzyri, Ola Hansson, Karl-Fredrik Eriksson, Leif Groop, Allan Vaag, Pernille Poulsen, Charlotte Ling. (2011) The expression of myosin heavy chain (MHC) genes in human skeletal muscle is related to metabolic characteristics involved in the pathogenesis of type 2 diabetes. Molecular Genetics and Metabolism 103:3, 275-281
CrossRef41
H. J. Lee, K. Chung, H. Lee, K. Lee, J. H. Lim, J. Song. (2011) Downregulation of mitochondrial lon protease impairs mitochondrial function and causes hepatic insulin resistance in human liver SK-HEP-1 cells. Diabetologia 54:6, 1437-1446
CrossRef42
Alison Sleigh, Philippa Raymond-Barker, Kerrie Thackray, David Porter, Mensud Hatunic, Alessandra Vottero, Christine Burren, Catherine Mitchell, Martin McIntyre, Soren Brage, T. Adrian Carpenter, Peter R. Murgatroyd, Kevin M. Brindle, Graham J. Kemp, Stephen O’Rahilly, Robert K. Semple, David B. Savage. (2011) Mitochondrial dysfunction in patients with primary congenital insulin resistance. Journal of Clinical Investigation 121:6, 2457-2461
CrossRef43
Ariane D. Minet, Michael Gaster. (2011) The dynamic equilibrium between ATP synthesis and ATP consumption is lower in isolated mitochondria from myotubes established from type 2 diabetic subjects compared to lean control. Biochemical and Biophysical Research Communications 409:4, 591-595
CrossRef44
Viduranga Y. Waisundara, Sing Yung Siu, Annie Hsu, Dejian Huang, Benny K.H. Tan. (2011) Baicalin upregulates the genetic expression of antioxidant enzymes in Type-2 diabetic Goto-Kakizaki rats. Life Sciences 88:23-24, 1016-1025
CrossRef45
Xuefei Gao, Kuai Li, Xiaoyan Hui, Xiangping Kong, Gary Sweeney, Yu Wang, Aimin Xu, Maikun Teng, Pentao Liu, Donghai Wu. (2011) Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase. Biochemical Journal 435:3, 723-732
CrossRef46
Stephen H. Caldwell, Curtis K. Argo. 2011. Non-Alcoholic Fatty Liver Disease and Nutrition. , 546-567.
CrossRef47
Xin Gao, Xiao-long Zhao, Yan-hui Zhu, Xiao-mu Li, Qiong Xu, Huan-dong Lin, Ming-Wei Wang. (2011) Tetramethylpyrazine protects palmitate-induced oxidative damage and mitochondrial dysfunction in C2C12 myotubes. Life Sciences 88:17-18, 803-809
CrossRef48
Ching-Jung Hsieh, Shao-Wen Weng, Chia-Wei Liou, Tsu-Kung Lin, Jin-Bor Chen, Mao-Meng Tiao, Yun-Ting Hung, I.-Ya Chen, Wen-Te Huang, Pei-Wen Wang. (2011) Tissue-specific differences in mitochondrial DNA content in type 2 diabetes. Diabetes Research and Clinical Practice 92:1, 106-110
CrossRef49
Elizabeth Hernández-Echeagaray, Nancy González, Angélica Ruelas, Ernesto Mendoza, Erika Rodríguez-Martínez, Rafael Antuna-Bizarro. (2011) Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle. Neurological Sciences 32:2, 241-254
CrossRef50
Magali Kitzmann, Louise Lantier, Sophie Hébrard, Jacques Mercier, Marc Foretz, Celine Aguer. (2011) Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:4, 423-430
CrossRef51
Joo Hyun Lim, Hyo Jung Lee, Youngmi Kim Pak, Won-Ho Kim, Jihyun Song. (2011) Organelle stress-induced activating transcription factor-3 downregulates low-density lipoprotein receptor expression in Sk-Hep1 human liver cells. Biological Chemistry 392:4, 377-385
CrossRef52
Elena Matteucci, Massimo Ghimenti, Cristina Consani, Maria Chiara Masoni, Ottavio Giampietro. (2011) Exploring Leukocyte Mitochondrial Membrane Potential in Type 1 Diabetes Families. Cell Biochemistry and Biophysics 59:2, 121-126
CrossRef53
Wanzhu Jin, Allison B. Goldfine, Tanner Boes, Robert R. Henry, Theodore P. Ciaraldi, Eun-Young Kim, Merve Emecan, Connor Fitzpatrick, Anish Sen, Ankit Shah, Edward Mun, Martha Vokes, Joshua Schroeder, Elizabeth Tatro, Jose Jimenez-Chillaron, Mary-Elizabeth Patti. (2011) Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. Journal of Clinical Investigation 121:3, 918-929
CrossRef54
Tetsuya Kubota, Naoto Kubota, Hiroki Kumagai, Shinichi Yamaguchi, Hideki Kozono, Takehiro Takahashi, Mariko Inoue, Shinsuke Itoh, Iseki Takamoto, Takayoshi Sasako, Katsuyoshi Kumagai, Tomoko Kawai, Shinji Hashimoto, Tsuneo Kobayashi, Maki Sato, Kumpei Tokuyama, Satoshi Nishimura, Masaki Tsunoda, Tomohiro Ide, Koji Murakami, Tomomi Yamazaki, Osamu Ezaki, Koichi Kawamura, Hirotake Masuda, Masao Moroi, Kaoru Sugi, Yuichi Oike, Hiroaki Shimokawa, Nobuyuki Yanagihara, Masato Tsutsui, Yasuo Terauchi, Kazuyuki Tobe, Ryozo Nagai, Katsuo Kamata, Kenji Inoue, Tatsuhiko Kodama, Kohjiro Ueki, Takashi Kadowaki. (2011) Impaired Insulin Signaling in Endothelial Cells Reduces Insulin-Induced Glucose Uptake by Skeletal Muscle. Cell Metabolism 13:3, 294-307
CrossRef55
Hideo Makimura, Takara L. Stanley, Noelle Sun, Jean M. Connelly, Linda C. Hemphill, Mirko I. Hrovat, David M. Systrom, Steven K. Grinspoon. (2011) Increased skeletal muscle phosphocreatine recovery after sub-maximal exercise is associated with increased carotid intima–media thickness. Atherosclerosis 215:1, 214-217
CrossRef56
D W Brock, B A Irving, B Gower, G R Hunter. (2011) Differences emerge in visceral adipose tissue accumulation after selection for innate cardiovascular fitness. International Journal of Obesity 35:2, 309-312
CrossRef57
M. Kacerovsky, A. Brehm, M. Chmelik, A. I. Schmid, J. Szendroedi, G. Kacerovsky-Bielesz, P. Nowotny, A. Lettner, M. Wolzt, J. G. Jones, M. Roden. (2011) Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes. Journal of Internal Medicine 269:2, 189-199
CrossRef58
Manuel Schiff, Paule Bénit, Assetou Coulibaly, Sandrine Loublier, Riyad El-Khoury, Pierre Rustin. (2011) Mitochondrial response to controlled nutrition in health and disease. Nutrition Reviews 69:2, 65-75
CrossRef59
Albrecht I. Schmid, Vera B. Schrauwen-Hinderling, Martin Andreas, Michael Wolzt, Ewald Moser, Michael Roden. (2011) Comparison of measuring energy metabolism by different 31P-magnetic resonance spectroscopy techniques in resting, ischemic, and exercising muscle. Magnetic Resonance in Medicinen/a-n/a
CrossRef60
Jean-Paul Decuypere, Giovanni Monaco, Ludwig Missiaen, Humbert De Smedt, Jan B. Parys, Geert Bultynck. (2011) IP3 Receptors, Mitochondria, and Ca2+ Signaling: Implications for Aging. Journal of Aging Research 2011, 1-20
CrossRef61
Thomas Koeck, Anders H. Olsson, Marloes Dekker Nitert, Vladimir V. Sharoyko, Claes Ladenvall, Olga Kotova, Erwin Reiling, Tina Rönn, Hemang Parikh, Jalal Taneera, Johan G. Eriksson, Metodi D. Metodiev, Nils-Göran Larsson, Alexander Balhuizen, Holger Luthman, Alena Stančáková, Johanna Kuusisto, Markku Laakso, Pernille Poulsen, Allan Vaag, Leif Groop, Valeriya Lyssenko, Hindrik Mulder, Charlotte Ling. (2011) A Common Variant in TFB1M Is Associated with Reduced Insulin Secretion and Increased Future Risk of Type 2 Diabetes. Cell Metabolism 13:1, 80-91
CrossRef62
Lu-Lu Chen, Hao-Hao Zhang, Juan Zheng, Xiang Hu, Wen Kong, Di Hu, Su-Xing Wang, Ping Zhang. (2011) Resveratrol attenuates high-fat diet–induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial β-oxidation. Metabolism 60:11, 1598
CrossRef63
Eiichiro Yamamoto, Osamu Yasuda, Keisuke Fukuo, Hiromi Rakugi, Toshio Ogihara, Hisao Ogawa. (2011) Crucial role of apoptogenic protein in cellular apoptosis and senescense. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 48:2, 138-141
CrossRef64
Soo Lim, Jean-Pierre Despres, Kwang Kon Koh. (2011) Prevention of Atherosclerosis in Overweight/Obese Patients. Circulation Journal 75:5, 1019-1027
CrossRef65
Bodil Bjørndal, Lena Burri, Vidar Staalesen, Jon Skorve, Rolf K. Berge. (2011) Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic Agents. Journal of Obesity 2011, 1-15
CrossRef66
Lakshminarasimhan Pavithra, Sreenivas Chavali, Samit Chattopadhyay. 2010. Nutritional Epigenetics. , 259-285.
CrossRef67
G. Giritharan, M. W. Li, F. De Sebastiano, F. J. Esteban, J. A. Horcajadas, K. C. K. Lloyd, A. Donjacour, E. Maltepe, P. F. Rinaudo. (2010) Effect of ICSI on gene expression and development of mouse preimplantation embryos. Human Reproduction 25:12, 3012-3024
CrossRef68
S. O. Crawford, R. C. Hoogeveen, F. L. Brancati, B. C. Astor, C. M. Ballantyne, M. I. Schmidt, J. H. Young. (2010) Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. International Journal of Epidemiology 39:6, 1647-1655
CrossRef69
Ariane D. Minet, Michael Gaster. (2010) ATP synthesis is impaired in isolated mitochondria from myotubes established from type 2 diabetic subjects. Biochemical and Biophysical Research Communications 402:1, 70-74
CrossRef70
Albert Lecube, Gabriel Sampol, Xavier Muñoz, Patricia Lloberes, Cristina Hernández, Rafael Simó. (2010) Insulin resistance is related to impaired lung function in morbidly obese women: a case-control study. Diabetes/Metabolism Research and Reviews 26:8, 639-645
CrossRef71
V. B. Matthews, T. L. Allen, S. Risis, M. H. S. Chan, D. C. Henstridge, N. Watson, L. A. Zaffino, J. R. Babb, J. Boon, P. J. Meikle, J. B. Jowett, M. J. Watt, J.-O. Jansson, C. R. Bruce, M. A. Febbraio. (2010) Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 53:11, 2431-2441
CrossRef72
Shiying Shao, Zhelong Liu, Yan Yang, Muxun Zhang, Xuefeng Yu. (2010) SREBP-1c, Pdx-1, and GLP-1R involved in palmitate-EPA regulated glucose-stimulated insulin secretion in INS-1 cells. Journal of Cellular Biochemistry 111:3, 634-642
CrossRef73
K. Y. Hur, H. S. Jung, M.-S. Lee. (2010) Role of autophagy in β-cell function and mass. Diabetes, Obesity and Metabolism 12, 20-26
CrossRef74
Soo Heon Kwak, Kyong Soo Park, Ki-Up Lee, Hong Kyu Lee. (2010) Mitochondrial metabolism and diabetes. Journal of Diabetes Investigation 1:5, 161-169
CrossRef75
Xiao-Hui Chen, Ya-Ping Zhao, Mei Xue, Chen-Bo Ji, Chun-Lin Gao, Jin-Gai Zhu, Da-Ni Qin, Chun-Zhao Kou, Xiao-Hong Qin, Mei-Ling Tong, Xi-Rong Guo. (2010) TNF-α induces mitochondrial dysfunction in 3T3-L1 adipocytes. Molecular and Cellular Endocrinology 328:1-2, 63-69
CrossRef76
Zhiyong Cheng, Yolanda Tseng, Morris F. White. (2010) Insulin signaling meets mitochondria in metabolism. Trends in Endocrinology & Metabolism 21:10, 589-598
CrossRef77
Josephine M. Forbes. (2010) The Physiological Deadlock between AMPK and Gluconeogenesis. The American Journal of Pathology 177:4, 1600-1602
CrossRef78
M. Hey-Mogensen, K. Højlund, B. F. Vind, L. Wang, F. Dela, H. Beck-Nielsen, M. Fernström, K. Sahlin. (2010) Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia 53:9, 1976-1985
CrossRef79
D. Samocha-Bonet, L. V. Campbell, A. Viardot, J. Freund, C. S. Tam, J. R. Greenfield, L. K. Heilbronn. (2010) A family history of type 2 diabetes increases risk factors associated with overfeeding. Diabetologia 53:8, 1700-1708
CrossRef80
Sherif Awad, Mary C. Stephenson, Elisa Placidi, Luca Marciani, Dumitru Constantin-Teodosiu, Penny A. Gowland, Robin C. Spiller, Kenneth C.H. Fearon, Peter G. Morris, Ian A. Macdonald, Dileep N. Lobo. (2010) The effects of fasting and refeeding with a ‘metabolic preconditioning’ drink on substrate reserves and mononuclear cell mitochondrial function. Clinical Nutrition 29:4, 538-544
CrossRef81
Jia Li, Caroline Romestaing, Xianlin Han, Yuan Li, Xinbao Hao, Yinyuan Wu, Chao Sun, Xiaolei Liu, Leonard S. Jefferson, Jingwei Xiong, Kathryn F. LaNoue, Zhijie Chang, Christopher J. Lynch, Huayan Wang, Yuguang Shi. (2010) Cardiolipin Remodeling by ALCAT1 Links Oxidative Stress and Mitochondrial Dysfunction to Obesity. Cell Metabolism 12:2, 154-165
CrossRef82
Aparajita Dey, Kavitha Swaminathan. (2010) Hyperglycemia-induced mitochondrial alterations in liver. Life Sciences 87:7-8, 197-214
CrossRef83
E. Phielix, R. Meex, E. Moonen-Kornips, M. K. C. Hesselink, P. Schrauwen. (2010) Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia 53:8, 1714-1721
CrossRef84
Leigh Perreault, Bryan C. Bergman, Devon M. Hunerdosse, Mary C. Playdon, Robert H. Eckel. (2010) Inflexibility in Intramuscular Triglyceride Fractional Synthesis Distinguishes Prediabetes From Obesity in Humans. Obesity 18:8, 1524-1531
CrossRef85
Kenneth Cusi. (2010) The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes. Current Diabetes Reports 10:4, 306-315
CrossRef86
J. A. Navarro, E. Ohmann, D. Sanchez, J. A. Botella, G. Liebisch, M. D. Molto, M. D. Ganfornina, G. Schmitz, S. Schneuwly. (2010) Altered lipid metabolism in a Drosophila model of Friedreich's ataxia. Human Molecular Genetics 19:14, 2828-2840
CrossRef87
Hans Hauner. 2010. Obesity and Diabetes. , 227-241.
CrossRef88
Tasneem Adam, Lionel H. Opie, M. Faadiel Essop. (2010) AMPK activation represses the human gene promoter of the cardiac isoform of acetyl-CoA carboxylase: Role of nuclear respiratory factor-1. Biochemical and Biophysical Research Communications 398:3, 495-499
CrossRef89
François R. Jornayvaz, Varman T. Samuel, Gerald I. Shulman. (2010) The Role of Muscle Insulin Resistance in the Pathogenesis of Atherogenic Dyslipidemia and Nonalcoholic Fatty Liver Disease Associated with the Metabolic Syndrome. Annual Review of Nutrition 30:1, 273-290
CrossRef90
Chih-Hao Wang, Ching-Chu Wang, Yau-Huei Wei. (2010) Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Annals of the New York Academy of Sciences 1201:1, 157-165
CrossRef91
Carmen E. Perrone, Dwight A.L. Mattocks, Maureen Jarvis-Morar, Jason D. Plummer, Norman Orentreich. (2010) Methionine restriction effects on mitochondrial biogenesis and aerobic capacity in white adipose tissue, liver, and skeletal muscle of F344 rats. Metabolism 59:7, 1000-1011
CrossRef92
Agnieszka Pazderska, Krzysztof Wanic, John J Nolan. (2010) Skeletal muscle mitochondrial dysfunction in Type 2 diabetes. Expert Review of Endocrinology & Metabolism 5:4, 475-477
CrossRef93
Hye Seung Jung, Myung-Shik Lee. (2010) Role of autophagy in diabetes and mitochondria. Annals of the New York Academy of Sciences 1201:1, 79-83
CrossRef94
Yutaka Nishigaki, Noriyuki Fuku, Masashi Tanaka. (2010) Mitochondrial haplogroups associated with lifestyle-related diseases and longevity in the Japanese population. Geriatrics & Gerontology International 10, S221-S235
CrossRef95
I-Chien Wu, Ikuroh Ohsawa, Noriyuki Fuku, Masashi Tanaka. (2010) Metabolic analysis of 13C-labeled pyruvate for noninvasive assessment of mitochondrial function. Annals of the New York Academy of Sciences 1201:1, 111-120
CrossRef96
Mark P. Keller, Alan D. Attie. (2010) Physiological Insights Gained from Gene Expression Analysis in Obesity and Diabetes. Annual Review of Nutrition 30:1, 341-364
CrossRef97
François R. Jornayvaz, Gerald I. Shulman. (2010) Regulation of mitochondrial biogenesis. Essays in Biochemistry 47:1, 69-84
CrossRef98
Ellen Lenaers, Henk M. De Feyter, Joris Hoeks, Patrick Schrauwen, Gert Schaart, Miranda Nabben, Klaas Nicolay, Jeanine J. Prompers, Matthijs K.C. Hesselink. (2010) Adaptations in Mitochondrial Function Parallel, but Fail to Rescue, the Transition to Severe Hyperglycemia and Hyperinsulinemia: A Study in Zucker Diabetic Fatty Rats. Obesity 18:6, 1100-1107
CrossRef99
C. Aguer, J. Mercier, C. Yong Wai Man, L. Metz, S. Bordenave, K. Lambert, E. Jean, L. Lantier, L. Bounoua, J. F. Brun, E. Raynaud de Mauverger, F. Andreelli, M. Foretz, M. Kitzmann. (2010) Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients. Diabetologia 53:6, 1151-1163
CrossRef100
Antonio Zorzano, María Isabel Hernández-Alvarez, Manuel Palacín, Geltrude Mingrone. (2010) Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1α or PGC-1β and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1797:6-7, 1028-1033
CrossRef101
Claudio C. Zoppi, Leonardo R. Silveira, Camila A. M. Oliveira, Antonio C. Boschero, Rui Curi, Everardo M. Carneiro. (2010) Insulin release, peripheral insulin resistance and muscle function in protein malnutrition: a role of tricarboxylic acid cycle anaplerosis. British Journal of Nutrition 103:09, 1237-1250
CrossRef102
Anthony E. Civitarese, Paul S. MacLean, Stacy Carling, Lyndal Kerr-Bayles, Ryan P. McMillan, Anson Pierce, Thomas C. Becker, Cedric Moro, Jean Finlayson, Natalie Lefort, Christopher B. Newgard, Lawrence Mandarino, William Cefalu, Ken Walder, Greg R. Collier, Matthew W. Hulver, Steven R. Smith, Eric Ravussin. (2010) Regulation of Skeletal Muscle Oxidative Capacity and Insulin Signaling by the Mitochondrial Rhomboid Protease PARL. Cell Metabolism 11:5, 412-426
CrossRef103
Dongyan Zhang, Jennifer Christianson, Zhen-Xiang Liu, Liqun Tian, Cheol Soo Choi, Susanne Neschen, Jianying Dong, Philip A. Wood, Gerald I. Shulman. (2010) Resistance to High-Fat Diet-Induced Obesity and Insulin Resistance in Mice with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency. Cell Metabolism 11:5, 402-411
CrossRef104
Carolina Gemma, Silvia Sookoian, Guillermo Dieuzeide, Silvia I. García, Tomas Fernández Gianotti, Claudio D. González, Carlos J. Pirola. (2010) Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents. Molecular Genetics and Metabolism 100:1, 83-87
CrossRef105
Shin-ichiro Imai, Leonard Guarente. (2010) Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends in Pharmacological Sciences 31:5, 212-220
CrossRef106
Masato Iwabu, Toshimasa Yamauchi, Miki Okada-Iwabu, Koji Sato, Tatsuro Nakagawa, Masaaki Funata, Mamiko Yamaguchi, Shigeyuki Namiki, Ryo Nakayama, Mitsuhisa Tabata, Hitomi Ogata, Naoto Kubota, Iseki Takamoto, Yukiko K. Hayashi, Naoko Yamauchi, Hironori Waki, Masashi Fukayama, Ichizo Nishino, Kumpei Tokuyama, Kohjiro Ueki, Yuichi Oike, Satoshi Ishii, Kenzo Hirose, Takao Shimizu, Kazushige Touhara, Takashi Kadowaki. (2010) Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1. Nature 464:7293, 1313-1319
CrossRef107
Catherine S. Mitchell, David B. Savage, Sylvie Dufour, Nadia Schoenmakers, Peter Murgatroyd, Douglas Befroy, David Halsall, Samantha Northcott, Philippa Raymond-Barker, Suzanne Curran, Elana Henning, Julia Keogh, Penny Owen, John Lazarus, Douglas L. Rothman, I. Sadaf Farooqi, Gerald I. Shulman, Krishna Chatterjee, Kitt Falk Petersen. (2010) Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. Journal of Clinical Investigation 120:4, 1345-1354
CrossRef108
Caroline B. Trapp, Neal D. Barnard. (2010) Usefulness of Vegetarian and Vegan Diets for Treating Type 2 Diabetes. Current Diabetes Reports 10:2, 152-158
CrossRef109
Darcy L Johannsen, Eric Ravussin. (2010) Obesity in the elderly: is faulty metabolism to blame?. Aging Health 6:2, 159-167
CrossRef110
Derek M Erion, Gerald I Shulman. (2010) Diacylglycerol-mediated insulin resistance. Nature Medicine 16:4, 400-402
CrossRef111
Scott P. Naples, Sarah J. Borengasser, R. Scott. Rector, Grace M. Uptergrove, E. Matthew Morris, Catherine R. Mikus, Lauren G. Koch, Steve L. Britton, Jamal A. Ibdah, John P. Thyfault. (2010) Skeletal muscle mitochondrial and metabolic responses to a high-fat diet in female rats bred for high and low aerobic capacity. Applied Physiology, Nutrition, and Metabolism 35:2, 151-162
CrossRef112
Alberto Mazza, Achille C Pessina, Sergio Zamboni, Edoardo Casiglia. (2010) Prognostic role of metabolic syndrome in the elderly is not greater than the sum of its components. Aging Health 6:2, 217-228
CrossRef113
Corey E. Tabit, William B. Chung, Naomi M. Hamburg, Joseph A. Vita. (2010) Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications. Reviews in Endocrine and Metabolic Disorders 11:1, 61-74
CrossRef114
Patrick Schrauwen, Vera Schrauwen-Hinderling, Joris Hoeks, Matthijs K.C. Hesselink. (2010) Mitochondrial dysfunction and lipotoxicity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1801:3, 266-271
CrossRef115
E. Zoico, A. Rossi, V. Di Francesco, A. Sepe, D. Olioso, F. Pizzini, F. Fantin, O. Bosello, L. Cominacini, T. B. Harris, M. Zamboni. (2010) Adipose Tissue Infiltration in Skeletal Muscle of Healthy Elderly Men: Relationships With Body Composition, Insulin Resistance, and Inflammation at the Systemic and Tissue Level. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 65A:3, 295-299
CrossRef116
William I. Sivitz, Mark A. Yorek. (2010) Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities. Antioxidants & Redox Signaling 12:4, 537-577
CrossRef117
Céline Aguer, Jacques Mercier, Magali Kitzmann. (2010) Lipid content and response to insulin are not invariably linked in human muscle cells. Molecular and Cellular Endocrinology 315:1-2, 225-232
CrossRef118
Dorit Samocha-Bonet, Leonie K. Heilbronn, Dov Lichtenberg, Lesley V. Campbell. (2010) Does skeletal muscle oxidative stress initiate insulin resistance in genetically predisposed individuals?. Trends in Endocrinology & Metabolism 21:2, 83-88
CrossRef119
Sean L. McGee, Mark Hargreaves. (2010) AMPK-mediated regulation of transcription in skeletal muscle. Clinical Science 118:8, 507-518
CrossRef120
Sandro M. Hirabara, Rui Curi, Pierre Maechler. (2010) Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. Journal of Cellular Physiology 222:1, 187
CrossRef121
Lisa Chow, Arthur From, Elizabeth Seaquist. (2010) Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. Metabolism 59:1, 70-85
CrossRef122
Rocco Barazzoni, XinXia Zhu, Mark DeBoer, Rakesh Datta, Michael D Culler, Michela Zanetti, Gianfranco Guarnieri, Daniel L Marks. (2010) Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney International 77:1, 23-28
CrossRef123
S-K Kim, S-W Park, I-J Hwang, Y-K Lee, Y-W Cho. (2010) High fat stores in ectopic compartments in men with newly diagnosed type 2 diabetes: an anthropometric determinant of carotid atherosclerosis and insulin resistance. International Journal of Obesity 34:1, 105-110
CrossRef124
Susanne Wiesner, Sven Haufe, Stefan Engeli, Harry Mutschler, Ute Haas, Friedrich C. Luft, Jens Jordan. (2010) Influences of Normobaric Hypoxia Training on Physical Fitness and Metabolic Risk Markers in Overweight to Obese Subjects. Obesity 18:1, 116-120
CrossRef125
Muhammad A. Abdul-Ghani, Ralph A. DeFronzo. (2010) Pathogenesis of Insulin Resistance in Skeletal Muscle. Journal of Biomedicine and Biotechnology 2010, 1-20
CrossRef126
Yu-Sik Kim, Il-Young Paik, Young-Jun Rhie, Sang-Hoon Suh. (2010) Integrative Physiology: Defined Novel Metabolic Roles of Osteocalcin. Journal of Korean Medical Science 25:7, 985
CrossRef127
Eun Hee Kim, Eun Hee Koh, Joong-Yeol Park, Ki-Up Lee. (2010) Adenine Nucleotide Translocator as a Regulator of Mitochondrial Function: Implication in the Pathogenesis of Metabolic Syndrome. Korean Diabetes Journal 34:3, 146
CrossRef128
Esther Phielix, Julia Szendroedi, Michael Roden. (2010) Mitochondrial Function and Insulin Resistance during Aging – A Mini-Review. Gerontology
CrossRef129
Erik P. Kirk, Samuel Klein. (2009) Pathogenesis and Pathophysiology of the Cardiometabolic Syndrome. The Journal of Clinical Hypertension 11:12, 761-765
CrossRef130
M. Schiff, S. Loublier, A. Coulibaly, P. Bénit, H. Ogier de Baulny, P. Rustin. (2009) Mitochondria and diabetes mellitus: untangling a conflictive relationship?. Journal of Inherited Metabolic Disease 32:6, 684-698
CrossRef131
Stephan F. E. Praet, Luc J. C. Loon. (2009) Exercise therapy in Type 2 diabetes. Acta Diabetologica 46:4, 263-278
CrossRef132
Wendy J. van der Spuy, Etheresia Pretorius. (2009) Is the use of resveratrol in the treatment and prevention of obesity premature?. Nutrition Research Reviews 22:02, 111
CrossRef133
, M. Stadler, G. Pacini, J. Petrie, A. Luger, C. Anderwald. (2009) Beta cell (dys)function in non-diabetic offspring of diabetic patients. Diabetologia 52:11, 2435-2444
CrossRef134
E. M. Byrne, A. F. McRae, D. L. Duffy, Z. Z. Zhao, N. G. Martin, J. B. Whitfield, P. M. Visscher, G. W. Montgomery. (2009) Family-based mitochondrial association study of traits related to type 2 diabetes and the metabolic syndrome in adolescents. Diabetologia 52:11, 2359-2368
CrossRef135
Kate S. Collison, Soad M. Saleh, Razan H. Bakheet, Rana K. Al-Rabiah, Angela L. Inglis, Nadine J. Makhoul, Zakia M. Maqbool, Marya Zia Zaidi, Mohammed A. Al-Johi, Futwan A. Al-Mohanna. (2009) Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS-55. Obesity 17:11, 2003-2013
CrossRef136
Brent A. Neuschwander-Tetri. (2009) Lifestyle Modification as the Primary Treatment of NASH. Clinics in Liver Disease 13:4, 649-665
CrossRef137
Kosta Steliou, Susan P. Perrine, Douglas V. Faller. (2009) Lactic acid in cancer and mitochondrial disease. Drug Development Research 70:7, 499-511
CrossRef138
Curtis K. Argo, Stephen H. Caldwell. (2009) Epidemiology and Natural History of Non-Alcoholic Steatohepatitis. Clinics in Liver Disease 13:4, 511-531
CrossRef139
Sherif Awad, Dumitru Constantin-Teodosiu, Ian A. Macdonald, Dileep N. Lobo. (2009) Short-term starvation and mitochondrial dysfunction – A possible mechanism leading to postoperative insulin resistance. Clinical Nutrition 28:5, 497-509
CrossRef140
Rozalyn Anderson, Tomas Prolla. (2009) PGC-1α in aging and anti-aging interventions. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:10, 1059-1066
CrossRef141
Viduranga Y. Waisundara, Annie Hsu, Benny Kwong-Huat Tan, Dejian Huang. (2009) Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabetes/Metabolism Research and Reviews 25:7, 671-677
CrossRef142
Su Xu, Jun Shen. (2009) Studying enzymes by in vivo 13C magnetic resonance spectroscopy. Progress in Nuclear Magnetic Resonance Spectroscopy 55:3, 266-283
CrossRef143
Antonio Zorzano, Marc Liesa, Manuel Palacín. (2009) Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. The International Journal of Biochemistry & Cell Biology 41:10, 1846-1854
CrossRef144
Chris Boesch. 2009. Human Muscle Studies by Magnetic Resonance Spectroscopy. .
CrossRef145
J. Wong, S. V. McLennan, L. Molyneaux, D. Min, S. M. Twigg, D. K. Yue. (2009) Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications. Diabetologia 52:9, 1953-1961
CrossRef146
J. Szendrödi, B. Rose, N.C. Schloot, M. Roden. (2009) Aktuelles zu den molekularen Grundlagen der Ernährung. Der Diabetologe 5:6, 432-441
CrossRef147
Mary-Elizabeth Patti, Sander M. Houten, Antonio C. Bianco, Raquel Bernier, P. Reed Larsen, Jens J. Holst, Michael K. Badman, Eleftheria Maratos-Flier, Edward C. Mun, Jussi Pihlajamaki, Johan Auwerx, Allison B. Goldfine. (2009) Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism. Obesity 17:9, 1671-1677
CrossRef148
M. I. Hernández-Alvarez, C. Chiellini, M. Manco, D. Naon, M. Liesa, M. Palacín, G. Mingrone, A. Zorzano. (2009) Genes involved in mitochondrial biogenesis/function are induced in response to bilio-pancreatic diversion in morbidly obese individuals with normal glucose tolerance but not in type 2 diabetic patients. Diabetologia 52:8, 1618-1627
CrossRef149
A. Kautzky-Willer, A. Handisurya. (2009) Metabolic diseases and associated complications: sex and gender matter!. European Journal of Clinical Investigation 39:8, 631-648
CrossRef150
Guadalupe Aparicio, Moisés B. Calvo, Vanessa Medina, Ovidio Fernández, Paula Jiménez, Martina Lema, Angélica Figueroa, Luis M. Antón Aparicio. (2009) Comprehensive lung injury pathology induced by mTOR inhibitors. Clinical and Translational Oncology 11:8, 499-510
CrossRef151
Rasmus Rabøl, Pernille F. Svendsen, Mette Skovbro, Robert Boushel, Steen B. Haugaard, Peter Schjerling, Patrick Schrauwen, Matthijs K.C. Hesselink, Lisbeth Nilas, Sten Madsbad, Flemming Dela. (2009) Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss. Metabolism 58:8, 1145-1152
CrossRef152
ALISON E. JENNINGS, ANGELA ALBERGA, RONALD J. SIGAL, OLLIE JAY, NORMAND G. BOULÉ, GLEN P. KENNY. (2009) The Effect of Exercise Training on Resting Metabolic Rate in Type 2 Diabetes Mellitus. Medicine & Science in Sports & Exercise 41:8, 1558-1565
CrossRef153
Michael Freemark. 2009. Childhood Obesity. , 530-558.
CrossRef154
G. Coppola, D. Marmolino, D. Lu, Q. Wang, M. Cnop, M. Rai, F. Acquaviva, S. Cocozza, M. Pandolfo, D. H. Geschwind. (2009) Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPAR pathway as a therapeutic target in Friedreich's ataxia. Human Molecular Genetics 18:13, 2452-2461
CrossRef155
Barry Braun, Benjamin Miller. 2009. Energy Requirements. , 1-21.
CrossRef156
Jia-Ying Yang, Hung-Yin Yeh, Kevin Lin, Ping H. Wang. (2009) Insulin stimulates Akt translocation to mitochondria: Implications on dysregulation of mitochondrial oxidative phosphorylation in diabetic myocardium. Journal of Molecular and Cellular Cardiology 46:6, 919-926
CrossRef157
Yan Bi, Mengyin Cai, Hua Liang, Weiping Sun, Xiubin Li, Chunxia Wang, Yanhua Zhu, Xiang Chen, Ming Li, Jianping Weng. (2009) Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory element–binding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in high-fat–diet and streptozotocin-induced diabetic rats. Metabolism 58:6, 779-786
CrossRef158
Kenneth Cusi. (2009) Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus. Current Diabetes Reports 9:3, 200-207
CrossRef159
Prasanth N. Surampudi, Jennifer John-Kalarickal, Vivian A. Fonseca. (2009) Emerging Concepts in the Pathophysiology of Type 2 Diabetes Mellitus. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76:3, 216-226
CrossRef160
J.-F. Dumas, G. Simard, M. Flamment, P.-H. Ducluzeau, P. Ritz. (2009) Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?. Diabetes & Metabolism 35:3, 159-167
CrossRef161
Bei B. Zhang, Gaochao Zhou, Cai Li. (2009) AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome. Cell Metabolism 9:5, 407-416
CrossRef162
Michael Gaster. (2009) Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects. Biochemical and Biophysical Research Communications 382:4, 766-770
CrossRef163
G. Zhou, I. K. Sebhat, B. B. Zhang. (2009) AMPK activators - potential therapeutics for metabolic and other diseases. Acta Physiologica 196:1, 175-190
CrossRef164
Neal D Barnard, Heather I Katcher, David JA Jenkins, Joshua Cohen, Gabrielle Turner-McGrievy. (2009) Vegetarian and vegan diets in type 2 diabetes management. Nutrition Reviews 67:5, 255-263
CrossRef165
Carles Cantó, Johan Auwerx. (2009) PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Current Opinion in Lipidology 20:2, 98-105
CrossRef166
D. K. Coletta, A. Sriwijitkamol, E. Wajcberg, P. Tantiwong, M. Li, M. Prentki, M. Madiraju, C. P. Jenkinson, E. Cersosimo, N. Musi, R. A. DeFronzo. (2009) Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial. Diabetologia 52:4, 723-732
CrossRef167
Nasser Mikhail. (2009) The metabolic syndrome: Insulin resistance. Current Hypertension Reports 11:2, 156-158
CrossRef168
N. Leibel,, W. Shen,, X. Mao,, M. Punyanitya,, D. Gallagher,, M. Horlick,, D.C. Shungu,, S.E. Oberfield,. (2009) Body Composition in Premature Adrenarche by Structural MRI, 'H MRS and DXA. Journal of Pediatric Endocrinology and Metabolism 22:4, 301-308
CrossRef169
E. Corpeleijn, W. H. M. Saris, E. E. Blaak. (2009) Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Obesity Reviews 10:2, 178-193
CrossRef170
János Fehér, László Váli, Anna Blázovics, Gabriella Lengyel. (2009) The beneficial effect of metadoxine (pyridoxine-pyrrolidone-carboxylate) in the treatment of fatty liver diseases. Clinical and Experimental Medical Journal 3:1, 65-79
CrossRef171
Josep Redon, Renata Cifkova, Stephane Laurent, Peter Nilsson, Krzysztof Narkiewicz, Serap Erdine, Giuseppe Mancia. (2009) Mechanisms of hypertension in the cardiometabolic syndrome. Journal of Hypertension 27:3, 441-451
CrossRef172
Iva Miljkovic, Laura M. Yerges, Hu Li, Christopher L. Gordon, Bret H. Goodpaster, Lewis H. Kuller, Cara S. Nestlerode, Clareann H. Bunker, Alan L. Patrick, Victor W. Wheeler, Joseph M. Zmuda. (2009) Association of the CPT1B Gene with Skeletal Muscle Fat Infiltration in Afro-Caribbean Men. Obesity
CrossRef173
Antonio Zorzano, Marc Liesa, Manuel Palacín. (2009) Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance. Archives Of Physiology And Biochemistry 115:1, 1-12
CrossRef174
X. Lopez, C. Bouché, E. Tatro, A. B. Goldfine. (2009) Family history of diabetes impacts on interactions between minimal model estimates of insulin sensitivity and glucose effectiveness. Diabetes, Obesity and Metabolism 11:2, 123-130
CrossRef175
Julia Szendroedi, Michael Roden. (2009) Ectopic lipids and organ function. Current Opinion in Lipidology 20:1, 50-56
CrossRef176
Jian-qing Wang, Jun Li, Yu-hong Zou, Wen-ming Cheng, Chao Lu, Lei Zhang, Jin-fang Ge, Cheng Huang, Yong Jin, Xiong-wen Lv, Cheng-mu Hu, Li-ping Liu. (2009) Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet. Journal of Ethnopharmacology 121:1, 54-60
CrossRef177
Lydia W.S. Finley, Marcia C. Haigis. (2009) The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Research Reviews 8:3, 173
CrossRef178
Lihua Chen, Chiwai Wong. (2009) Estrogen-Related Receptor α Inverse Agonist Enhances Basal Glucose Uptake in Myotubes through Reactive Oxygen Species. Biological & Pharmaceutical Bulletin 32:7, 1199-1203
CrossRef179
Jung Eun Lee, Hansoo Park, Young Seok Ju, Minhye Kwak, Jong-Il Kim, Ha Young Oh, Jeong-Sun Seo. (2009) Higher mitochondrial DNA copy number is associated with lower prevalence of microalbuminuria. Experimental and Molecular Medicine 41:4, 253
CrossRef180
Si Young Cho, Pil Joon Park, Eui Seok Shin, Jung Ho Lee, Hui Kyoung Chang, Tae Ryong Lee. (2009) Proteomic analysis of mitochondrial proteins of basal and lipolytically (isoproterenol and TNF-α)-stimulated adipocytes. Journal of Cellular Biochemistry 106:2, 257
CrossRef181
Toni Kim, J. Wayne Leitner, Rebecca Adochio, Boris Draznin. (2009) Knockdown of JNK rescues 3T3-L1 adipocytes from insulin resistance induced by mitochondrial dysfunction. Biochemical and Biophysical Research Communications 378:4, 772-776
CrossRef182
Soo Lim, Kyu R. Son, In C. Song, Ho S. Park, Cheng J. Jin, Hak C. Jang, Kyong S. Park, Young-Bum Kim, Hong K. Lee. (2009) Fat in Liver/Muscle Correlates More Strongly With Insulin Sensitivity in Rats Than Abdominal Fat. Obesity 17:1, 188-195
CrossRef183
Anne Maagaard, Dag Kvale. (2009) Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicity. Scandinavian Journal of Infectious Diseases 41:11-12, 808-817
CrossRef184
Shao-Wen Weng, Tsu-Kung Lin, Chia-Wei Liou, Shang-Der Chen, Yau-Huei Wei, Hsin-Chen Lee, I-Ya Chen, Ching-Jung Hsieh, Pei-Wen Wang. (2009) Peripheral blood mitochondrial DNA content and dysregulation of glucose metabolism. Diabetes Research and Clinical Practice 83:1, 94-99
CrossRef185
Jihoon Kim, Lee Young Lee, Sihoon Lee. (2009) Assessment of Insulin Resistance and Its Clinical Application. Journal of Korean Endocrine Society 24:2, 75
CrossRef186
Jeong Hyun Park. (2009) Mitochondria DNA Polymorphism and Type 2 Diabetes Mellitus. Korean Diabetes Journal 33:5, 373
CrossRef187
G GUARNIERI, M ZANETTI, P VINCI, M CATTIN, R BARAZZONI. (2009) Insulin Resistance in Chronic Uremia. Journal of Renal Nutrition 19:1, 20-24
CrossRef188
Marinette van der Graaf, Cees J. Tack, Jacco H. de Haan, Dennis W. J. Klomp, Arend Heerschap. (2009) Magnetic resonance spectroscopy shows an inverse correlation between intramyocellular lipid content in human calf muscle and local glycogen synthesis rate. NMR in Biomedicinen/a-n/a
CrossRef189
Anthony Khuu, Jimin Ren, Ivan Dimitrov, Donald Woessner, James Murdoch, A. Dean Sherry, Craig R. Malloy. (2009) Orientation of lipid strands in the extracellular compartment of muscle: Effect on quantitation of intramyocellular lipids. Magnetic Resonance in Medicine 61:1, 16-21
CrossRef190
Patrick W. G. Mallon, Rebecca Sedwell, Gary Rogers, David Nolan, Patrick Unemori, Jennifer Hoy, Katherine Samaras, Anthony Kelleher, Sean Emery, David A. Cooper, Andrew Carr, . (2008) Effect of Rosiglitazone on Peroxisome Proliferator‐Activated Receptor γ Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug–Induced Mitochondrial Dysfunction. The Journal of Infectious Diseases 198:12, 1794-1803
CrossRef191
Cristina Lara-Castro, W. Timothy Garvey. (2008) Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome. Endocrinology & Metabolism Clinics of North America 37:4, 841-856
CrossRef192
Stephen O. Crawford, Marietta S. Ambrose, Ron C. Hoogeveen, Frederick L. Brancati, Christie M. Ballantyne, J. Hunter Young. (2008) Association of Lactate With Blood Pressure Before and After Rapid Weight Loss. American Journal of Hypertension 21:12, 1337-1342
CrossRef193
Donal J. O'Gorman, Anna Krook. (2008) Exercise and the Treatment of Diabetes and Obesity. Endocrinology & Metabolism Clinics of North America 37:4, 887-903
CrossRef194
J. Szendroedi, M. Roden. (2008) Mitochondrial fitness and insulin sensitivity in humans. Diabetologia 51:12, 2155-2167
CrossRef195
Toshinari Takamura, Hirofumi Misu, Naoto Matsuzawa-Nagata, Masaru Sakurai, Tsuguhito Ota, Akiko Shimizu, Seiichiro Kurita, Yumie Takeshita, Hitoshi Ando, Masao Honda, Shuichi Kaneko. (2008) Obesity Upregulates Genes Involved in Oxidative Phosphorylation in Livers of Diabetic Patients. Obesity 16:12, 2601-2609
CrossRef196
J. Girard, M. Lafontan. (2008) Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism. Diabetes & Metabolism 34:5, 439-445
CrossRef197
N. L. Julie, I. M. Julie, A. I. Kende, G. L. Wilson. (2008) Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone. Diabetologia 51:11, 2108-2116
CrossRef198
C. M. Frederiksen, K. Højlund, L. Hansen, E. J. Oakeley, B. Hemmings, B. M. Abdallah, K. Brusgaard, H. Beck-Nielsen, M. Gaster. (2008) Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia 51:11, 2068-2077
CrossRef199
Brittany Yerby, Richard Deacon, Valerie Beaulieu, Jinsheng Liang, Jiaping Gao, Didier Laurent. (2008) Insulin-stimulated mitochondrial adenosine triphosphate synthesis is blunted in skeletal muscles of high-fat–fed rats. Metabolism 57:11, 1584-1590
CrossRef200
Nigel Turner, Leonie K. Heilbronn. (2008) Is mitochondrial dysfunction a cause of insulin resistance?. Trends in Endocrinology & Metabolism 19:9, 324-330
CrossRef201
D. E. Befroy, K. F. Petersen, S. Dufour, G. F. Mason, D. L. Rothman, G. I. Shulman. (2008) Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals. Proceedings of the National Academy of Sciences 105:43, 16701-16706
CrossRef202
Jun Yin, Jianping Ye. 2008. Management of Insulin Resistance with Chinese Herbs. , 249-266.
CrossRef203
L. J. Tamariz, J. H. Young, J. S. Pankow, H.-C. Yeh, M. I. Schmidt, B. Astor, F. L. Brancati. (2008) Blood Viscosity and Hematocrit as Risk Factors for Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology 168:10, 1153-1160
CrossRef204
Leonardo R. Silveira, Jarlei Fiamoncini, Sandro M. Hirabara, Joaquim Procópio, Tavane D. Cambiaghi, Carlos Hermano J. Pinheiro, Lúcia R. Lopes, Rui Curi. (2008) Updating the effects of fatty acids on skeletal muscle. Journal of Cellular Physiology 217:1, 1-12
CrossRef205
Armin Heufelder. (2008) Testosterone, the metabolic syndrome and diabetes mellitus. Journal of Men's Health 5, S11-S17
CrossRef206
P. Schrauwen, M. K. C. Hesselink. (2008) Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?. Diabetologia 51:9, 1694-1697
CrossRef207
Mélissa Flamment, Matthieu Arvier, Yves Gallois, Gilles Simard, Yves Malthièry, Patrick Ritz, Pierre-Henri Ducluzeau. (2008) Fatty liver and insulin resistance in obese Zucker rats: No role for mitochondrial dysfunction. Biochimie 90:9, 1407-1413
CrossRef208
Kurt Højlund, Martin Mogensen, Kent Sahlin, Henning Beck-Nielsen. (2008) Mitochondrial Dysfunction in Type 2 Diabetes and Obesity. Endocrinology & Metabolism Clinics of North America 37:3, 713-731
CrossRef209
Andrew Abdel-Sayed, Christophe Binnert, Kim-Anne Lê, Murielle Bortolotti, Philippe Schneiter, Luc Tappy. (2008) A high-fructose diet impairs basal and stress-mediated lipid metabolism in healthy male subjects. British Journal of Nutrition 100:02,
CrossRef210
Mohammed A. Alsaif. (2008) Effect of N. sativa Oil on Impaired Glucose Tolerance and Insulin Insensitivity Induced by High-Fat-Diet and Turpentine-Induced Trauma. Pakistan Journal of Biological Sciences 11:8, 1093-1099
CrossRef211
Pei-Wen Wang, Ching-Jung Hsieh, Leung-Chit Psang, Yu-Fan Cheng, Chia-Wei Liou, Shao-Wen Weng, Jung-Fu Chen, I-Ya Chen, Rong-Hwai Li, Hock-Liew Eng. (2008) Fatty liver and chronic inflammation in Chinese adults. Diabetes Research and Clinical Practice 81:2, 202-208
CrossRef212
Thomas P.J. Solomon, Christine M. Marchetti, Raj K. Krishnan, Frank Gonzalez, John P. Kirwan. (2008) Effects of aging on basal fat oxidation in obese humans. Metabolism 57:8, 1141-1147
CrossRef213
George L. King. (2008) The Role of Inflammatory Cytokines in Diabetes and Its Complications. Journal of Periodontology 79:8s, 1527-1534
CrossRef214
T. Rönn, P. Poulsen, O. Hansson, J. Holmkvist, P. Almgren, P. Nilsson, T. Tuomi, B. Isomaa, L. Groop, A. Vaag, C. Ling. (2008) Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia 51:7, 1159-1168
CrossRef215
Kenneth Maiese, Zhao Zhong Chong, Faqi Li, Yan Chen Shang. (2008) Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies. Progress in Neurobiology 85:2, 194-213
CrossRef216
A Viardot, L K Heilbronn, H Herzog, S Gregersen, L V Campbell. (2008) Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes. International Journal of Obesity 32:6, 943-948
CrossRef217
Muhammad A. Abdul-Ghani, Ralph A. DeFronzo. (2008) Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Current Diabetes Reports 8:3, 173-178
CrossRef218
A. I. Schmid, M. Chmelík, J. Szendroedi, M. Krššák, A. Brehm, E. Moser, M. Roden. (2008) Quantitative ATP synthesis in human liver measured by localized31P spectroscopy using the magnetization transfer experiment. NMR in Biomedicine 21:5, 437-443
CrossRef219
C. R. Hancock, D.-H. Han, M. Chen, S. Terada, T. Yasuda, D. C. Wright, J. O. Holloszy. (2008) High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proceedings of the National Academy of Sciences 105:22, 7815-7820
CrossRef220
E. W. Kraegen, G. J. Cooney, N. Turner. (2008) Muscle insulin resistance: A case of fat overconsumption, not mitochondrial dysfunction. Proceedings of the National Academy of Sciences 105:22, 7627-7628
CrossRef221
Adilson Guilherme, Joseph V. Virbasius, Vishwajeet Puri, Michael P. Czech. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology 9:5, 367-377
CrossRef222
Esther Phielix, Marco Mensink. (2008) Type 2 Diabetes Mellitus and Skeletal Muscle Metabolic Function. Physiology & Behavior 94:2, 252-258
CrossRef223
H. Yokoyama, K. Mori, M. Emoto, T. Araki, M. Teramura, K. Mochizuki, T. Tashiro, K. Motozuka, Y. Inoue, Y. Nishizawa. (2008) Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise. Diabetes, Obesity and Metabolism 10:5, 400-407
CrossRef224
Eva Corpeleijn, Marco Mensink, Marianne E. Kooi, Paul M.H.J. Roekaerts, Wim H.M. Saris, Ellen E. Blaak. (2008) Impaired Skeletal Muscle Substrate Oxidation in Glucose-intolerant Men Improves After Weight Loss. Obesity 16:5, 1025-1032
CrossRef225
Edward A. Hurvitz, Liza B. Green, Joseph E. Hornyak, Seema R. Khurana, Lauren Gerard Koch. (2008) Body Mass Index Measures in Children with Cerebral Palsy Related to Gross Motor Function Classification. American Journal of Physical Medicine & Rehabilitation 87:5, 395-403
CrossRef226
Vance B. Matthews, Mark A. Febbraio. (2008) CNTF: a target therapeutic for obesity-related metabolic disease?. Journal of Molecular Medicine 86:4, 353-361
CrossRef227
Helena Cortez-Pinto, Mariana Machado. (2008) Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2:2, 217-231
CrossRef228
C. Anderwald, G. Pfeiler, P. Nowotny, M. Anderwald-Stadler, M. Krebs, M. G. Bischof, M. Kozakova, A. Luger, G. Pacini, M. Roden, W. Waldhäusl. (2008) Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring. European Journal of Clinical Investigation 38:4, 227-237
CrossRef229
K. S. Park, J. C. Chan, L.-M. Chuang, S. Suzuki, E. Araki, K. Nanjo, L. Ji, M. Ng, M. Nishi, H. Furuta, T. Shirotani, B. Y. Ahn, S. S. Chung, H.-K. Min, S. W. Lee, J. H. Kim, Y. M. Cho, H. K. Lee, . (2008) A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia 51:4, 602-608
CrossRef230
Ki-Up Lee, Eun Hee Koh, Min-Seon Kim, Joong-Yeol Park, Eun Hee Cho. 2008. Effects of Alpha-Lipoic Acid on AMP-Activated Protein Kinase in Different Tissues. .
CrossRef231
Masanori Mitsuishi, Kazutoshi Miyashita, Hiroshi Itoh. (2008) cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes. Biochemical and Biophysical Research Communications 367:4, 840-845
CrossRef232
Merav Fraenkel, Ram Weiss, Ilit Leizerman, Debbie Anaby, Eliahu Golomb, Gil Leibowitz, Nurit Kaiser. (2008) Scanning Electron Microscopic Analysis of Intramyocellular Lipid Droplets in an Animal Model of Type 2 Diabetes. Obesity 16:3, 695-699
CrossRef233
Hyeonjin Kim, Sara E. Taksali, Sylvie Dufour, Douglas Befroy, T. Robin Goodman, Kitt Falk Petersen, Gerald I. Shulman, Sonia Caprio, R. Todd Constable. (2008) Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. Magnetic Resonance in Medicine 59:3, 521-527
CrossRef234
N Squillace, G Lapadula, C Torti, G Orlando, S Mandalia, G Nardini, B Beghetto, S Costarelli, G Guaraldi. (2008) Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study. HIV Medicine 9:3, 151-159
CrossRef235
Darleen Sandoval, Daniela Cota, Randy J. Seeley. (2008) The Integrative Role of CNS Fuel-Sensing Mechanisms in Energy Balance and Glucose Regulation. Annual Review of Physiology 70:1, 513-535
CrossRef236
Emilie Chanseaume, Guy Bielicki, Anne-Laure Tardy, Jean-Pierre Renou, Damien Freyssenet, Yves Boirie, Béatrice Morio. (2008) Impaired Resting Muscle Energetics Studied by 31P-NMR in Diet-induced Obese Rats. Obesity 16:3, 572-577
CrossRef237
Lawrence C. Perlmuter, Sant P. Singh, Julia M. Gabhart, Ramona Pungan, Monika Siedlarz. (2008) Parents Matter: Intergenerational Influences of Diabetes Mellitus on Glycemic Control and Morbidity in Older Type 2 Diabetic Males. Experimental Aging Research 34:2, 138-151
CrossRef238
Sarah Crunkhorn, Mary-Elizabeth Patti. (2008) Links between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?. Thyroid 18:2, 227-237
CrossRef239
Charles Thomas, Johan Auwerx, Kristina Schoonjans. (2008) Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism. Thyroid 18:2, 167-174
CrossRef240
Matthew R. Jackman, E. Ravussin, M.J. Rowe, R. Pratley, M.R. Milner, W.T. Willis. (2008) Effect of a Polymorphism in the ND1 Mitochondrial Gene on Human Skeletal Muscle Mitochondrial Function. Obesity 16:2, 363-368
CrossRef241
Joris Hoeks, Jacob J. Briedé, Johan de Vogel, Gert Schaart, Miranda Nabben, Esther Moonen-Kornips, Matthijs K.C. Hesselink, Patrick Schrauwen. (2008) Mitochondrial function, content and ROS production in rat skeletal muscle: Effect of high-fat feeding. FEBS Letters 582:4, 510-516
CrossRef242
Mark A. Tarnopolsky, Adeel Safdar. (2008) The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults. Applied Physiology, Nutrition, and Metabolism 33:1, 213-227
CrossRef243
M. Ristow. (2008) Glukosestoffwechsel und Tumorwachstum. Der Onkologe 14:1, 22-30
CrossRef244
S. Glund, A. Krook. (2008) Role of interleukin-6 signalling in glucose and lipid metabolism. Acta Physiologica 192:1, 37-48
CrossRef245
José A Lumini, José Magalhães, Paulo J Oliveira, António Ascensão. (2008) Beneficial Effects of Exercise on Muscle Mitochondrial Function in Diabetes Mellitus. Sports Medicine 38:9, 735-750
CrossRef246
Matthew J. Watt, Andrea L. Hevener. (2008) Fluxing the Mitochondria to Insulin Resistance. Cell Metabolism 7:1, 5-6
CrossRef247
Kristin Eckardt, Henrike Sell, Juergen Eckel. (2008) Novel aspects of adipocyte-induced skeletal muscle insulin resistance. Archives Of Physiology And Biochemistry 114:4, 287-298
CrossRef248
M. Kaaman, L. M. Sparks, V. Harmelen, S. R. Smith, E. Sjölin, I. Dahlman, P. Arner. (2007) Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia 50:12, 2526-2533
CrossRef249
Daniel L Morganstein, Malcolm G Parker. (2007) Role of nuclear receptor coregulators in metabolism. Expert Review of Endocrinology & Metabolism 2:6, 797-807
CrossRef250
Charlotte Ling, Pernille Poulsen, Stina Simonsson, Tina Rönn, Johan Holmkvist, Peter Almgren, Per Hagert, Emma Nilsson, Amanda G. Mabey, Peter Nilsson, Allan Vaag, Leif Groop. (2007) Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. Journal of Clinical Investigation 117:11, 3427-3435
CrossRef251
Vera B Schrauwen-Hinderling, Michael Roden, M Eline Kooi, Matthijs KC Hesselink, Patrick Schrauwen. (2007) Muscular mitochondrial dysfunction and type 2 diabetes mellitus. Current Opinion in Clinical Nutrition and Metabolic Care 10:6, 698-703
CrossRef252
Christoph Handschin, Cheol Soo Choi, Sherry Chin, Sheene Kim, Dan Kawamori, Amarnath J. Kurpad, Nicole Neubauer, Jiang Hu, Vamsi K. Mootha, Young-Bum Kim, Rohit N. Kulkarni, Gerald I. Shulman, Bruce M. Spiegelman. (2007) Abnormal glucose homeostasis in skeletal muscle–specific PGC-1α knockout mice reveals skeletal muscle–pancreatic β cell crosstalk. Journal of Clinical Investigation 117:11, 3463-3474
CrossRef253
S. R. Stannard, M. A. Holdaway, T. Sachinwalla, C. W. Cunningham. (2007) Insulin sensitivity and intramyocellular lipid concentrations in young Maori men. Diabetic Medicine 24:11, 1205-1212
CrossRef254
Hiroyuki Sato, Cédric Genet, Axelle Strehle, Charles Thomas, Annelise Lobstein, Alain Wagner, Charles Mioskowski, Johan Auwerx, Régis Saladin. (2007) Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochemical and Biophysical Research Communications 362:4, 793-798
CrossRef255
J. Andrew Pospisilik, Claude Knauf, Nicholas Joza, Paule Benit, Michael Orthofer, Patrice D. Cani, Ingo Ebersberger, Tomoki Nakashima, Renu Sarao, Gregory Neely, Harald Esterbauer, Andrey Kozlov, C. Ronald Kahn, Guido Kroemer, Pierre Rustin, Remy Burcelin, Josef M. Penninger. (2007) Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes. Cell 131:3, 476-491
CrossRef256
Anthony E Civitarese, Steven R Smith, Eric Ravussin. (2007) Diet, energy metabolism and mitochondrial biogenesis. Current Opinion in Clinical Nutrition and Metabolic Care 10:6, 679-687
CrossRef257
D. Zhang, Z.-X. Liu, C. S. Choi, L. Tian, R. Kibbey, J. Dong, G. W. Cline, P. A. Wood, G. I. Shulman. (2007) Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proceedings of the National Academy of Sciences 104:43, 17075-17080
CrossRef258
WanHua Lei, HuiXue Liu, LiJun Zhong, XiaoDa Yang, Kui Wang. (2007) Vanadyl ions binding to GroEL (HSP60) and inducing its depolymerization. Chinese Science Bulletin 52:20, 2775-2781
CrossRef259
J. F. Hocquette, S. Tesseraud, I. Cassar-Malek, Y. Chilliard, I. Ortigues-Marty. (2007) Responses to nutrients in farm animals: implications for production and quality. animal 1:09,
CrossRef260
M. Straczkowski, I. Kowalska, M. Baranowski, A. Nikolajuk, E. Otziomek, P. Zabielski, A. Adamska, A. Blachnio, J. Gorski, M. Gorska. (2007) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50:11, 2366-2373
CrossRef261
David C. Wright. (2007) Mechanisms of calcium-induced mitochondrial biogenesis and GLUT4 synthesis. Applied Physiology, Nutrition, and Metabolism 32:5, 840-845
CrossRef262
Jeffrey F. Horowitz. (2007) Exercise-Induced Alterations in Muscle Lipid Metabolism Improve Insulin Sensitivity. Exercise and Sport Sciences Reviews 35:4, 192-196
CrossRef263
L Lionetti, M P Mollica, R Crescenzo, E D'Andrea, M Ferraro, F Bianco, G Liverini, S Iossa. (2007) Skeletal muscle subsarcolemmal mitochondrial dysfunction in high-fat fed rats exhibiting impaired glucose homeostasis. International Journal of Obesity 31:10, 1596-1604
CrossRef264
Zhidan Wu, Olivier Boss. (2007) Targeting PGC-1α to control energy homeostasis. Expert Opinion on Therapeutic Targets 11:10, 1329-1338
CrossRef265
Alison C. Holloway, Donald Q. Cuu, Katherine M. Morrison, Hertzel C. Gerstein, Mark A. Tarnopolsky. (2007) Transgenerational effects of fetal and neonatal exposure to nicotine. Endocrine 31:3, 254-259
CrossRef266
K. J. Nadeau, L. B. Ehlers, L. E. Aguirre, J. E. B. Reusch, B. Draznin. (2007) Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone. Diabetes, Obesity and Metabolism 9:5, 714-723
CrossRef267
Young Min Cho, Kyong Soo Park, Hong Kyu Lee. (2007) Genetic factors related to mitochondrial function and risk of diabetes mellitus. Diabetes Research and Clinical Practice 77:3, S172-S177
CrossRef268
M. I. Trenell, J. A. Ward, B. J. Yee, C. L. Phillips, G. J. Kemp, R. R. Grunstein, C. H. Thompson. (2007) Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes, Obesity and Metabolism 9:5, 679-687
CrossRef269
M Mensink, M K C Hesselink, A P Russell, G Schaart, J-P Sels, P Schrauwen. (2007) Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. International Journal of Obesity 31:8, 1302-1310
CrossRef270
Kim-Anne L??, Luc Tappy, David A D??Alessio. (2007) Mitochondrial dysfunction and insulin resistance: a matter of lifestyle?. Current Opinion in Clinical Nutrition and Metabolic Care 10:4, 494-497
CrossRef271
Roberto Scatena, Patrizia Bottoni, Giuseppe E. Martorana, Federica Vincenzoni, Giorgia Botta, Paola Pastore, Bruno Giardina. (2007) Mitochondria, ciglitazone and liver: A neglected interaction in biochemical pharmacology. European Journal of Pharmacology 567:1-2, 50-58
CrossRef272
Syed Shah, Muhammad Iqbal, Jocelyne Karam, Moro Salifu, Samy I. McFarlane. (2007) Oxidative Stress, Glucose Metabolism, and the Prevention of Type 2 Diabetes: Pathophysiological Insights. Antioxidants & Redox Signaling 9:7, 911-929
CrossRef273
Jérôme N. Feige, Johan Auwerx. (2007) Transcriptional coregulators in the control of energy homeostasis. Trends in Cell Biology 17:6, 292-301
CrossRef274
Simon Schenk, Jeffrey F. Horowitz. (2007) Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid–induced insulin resistance. Journal of Clinical Investigation 117:6, 1690-1698
CrossRef275
Dominique Pessayre. (2007) Role of mitochondria in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 22:s1, S20-S27
CrossRef276
Pierpaolo De Feo, Vilberto Stocchi. (2007) Physical activity for the treatment and prevention of metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases 17:5, 327-331
CrossRef277
Igor Vivanco, Nicolaos Palaskas, Chris Tran, Stephen P. Finn, Gad Getz, Norman J. Kennedy, Jing Jiao, Joshua Rose, Wanling Xie, Massimo Loda, Todd Golub, Ingo K. Mellinghoff, Roger J. Davis, Hong Wu, Charles L. Sawyers. (2007) Identification of the JNK Signaling Pathway as a Functional Target of the Tumor Suppressor PTEN. Cancer Cell 11:6, 555-569
CrossRef278
D. Pomplun, A. Voigt, T. J. Schulz, R. Thierbach, A. F. Pfeiffer, M. Ristow. (2007) Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity. Proceedings of the National Academy of Sciences 104:15, 6377-6381
CrossRef279
Zachary Gerhart-Hines, Joseph T Rodgers, Olivia Bare, Carles Lerin, Seung-Hee Kim, Raul Mostoslavsky, Frederick W Alt, Zhidan Wu, Pere Puigserver. (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. The EMBO Journal 26:7, 1913-1923
CrossRef280
Mark A. Febbraio. (2007) gp130 receptor ligands as potential therapeutic targets for obesity. Journal of Clinical Investigation 117:4, 841-849
CrossRef281
Pooi-See Chan, Renu A Kowluru. (2007) Role of retinal mitochondria in the development of diabetic retinopathy. Expert Review of Ophthalmology 2:2, 237-247
CrossRef282
Cecilia M Shikuma, Yang Yang, Marshall J Glesby, William A Meyer, Karen T Tashima, Heather J Ribaudo, Nancy Webb, Barbara Bastow, Daniel R Kuritzkes, Roy M Gulick. (2007) Metabolic Effects of Protease Inhibitor-Sparing Antiretroviral Regimens Given as Initial Treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095). JAIDS Journal of Acquired Immune Deficiency Syndromes 44:5, 540-550
CrossRef283
R. Stark, M. Roden. (2007) Mitochondrial function and endocrine diseases. European Journal of Clinical Investigation 37:4, 236-248
CrossRef284
Emilie Chanseaume, Christophe Giraudet, Céline Gryson, Stéphane Walrand, Paulette Rousset, Yves Boirie, Béatrice Morio. (2007) Enhanced Muscle Mixed and Mitochondrial Protein Synthesis Rates after a High-fat or High-sucrose Diet*. Obesity 15:4, 853-859
CrossRef285
Craig J. McMackin, Michael E. Widlansky, Naomi M. Hamburg, Alex L. Huang, Susan Weller, Monika Holbrook, Noyan Gokce, Tory M. Hagen, John F. Keaney, Joseph A. Vita. (2007) Effect of Combined Treatment With α-Lipoic Acid and Acetyl-L-Carnitine on Vascular Function and Blood Pressure in Patients With Coronary Artery Disease. The Journal of Clinical Hypertension 9:4, 249-255
CrossRef286
J. A. Timmons, K. Wennmalm, O. Larsson, T. B. Walden, T. Lassmann, N. Petrovic, D. L. Hamilton, R. E. Gimeno, C. Wahlestedt, K. Baar, J. Nedergaard, B. Cannon. (2007) Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proceedings of the National Academy of Sciences 104:11, 4401-4406
CrossRef287
J. A. Hawley, S. J. Lessard. (2007) Mitochondrial function: use it or lose it. Diabetologia 50:4, 699-702
CrossRef288
R. Boushel, E. Gnaiger, P. Schjerling, M. Skovbro, R. Kraunsøe, F. Dela. (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50:4, 790-796
CrossRef289
Jolita Ciapaite, Stephan J.L. Bakker, Gerco Van Eikenhorst, Marijke J. Wagner, Tom Teerlink, Casper G. Schalkwijk, Mariann Fodor, D. Margriet Ouwens, Michaela Diamant, Robert J. Heine, Hans V. Westerhoff, Klaas Krab. (2007) Functioning of oxidative phosphorylation in liver mitochondria of high-fat diet fed rats. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1772:3, 307-316
CrossRef290
Eiichi Araki, Jun-Ichi Miyazaki. (2007) Metabolic Disorders in Diabetes Mellitus: Impact of Mitochondrial Function and Oxidative Stress on Diabetes and Its Complications. Antioxidants & Redox Signaling 9:3, 289-291
CrossRef291
Brent A Neuschwander-Tetri. (2007) Fatty liver and the metabolic syndrome. Current Opinion in Gastroenterology 23:2, 193-198
CrossRef292
Torben Østergård, Niels Jessen, Ole Schmitz, Lawrence J. Mandarino. (2007) The effect of exercise, training, and inactivity on insulin sensitivity in diabetics and their relatives: what is new?. Applied Physiology, Nutrition, and Metabolism 32:3, 541-548
CrossRef293
Takeshi Nishikawa, Eiichi Araki. (2007) Impact of Mitochondrial ROS Production in the Pathogenesis of Diabetes Mellitus and Its Complications. Antioxidants & Redox Signaling 9:3, 343-353
CrossRef294
Noriyuki Fuku, Kyong Soo Park, Yoshiji Yamada, Yutaka Nishigaki, Young Min Cho, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Kiyoshi Yokoi, Yoshinori Nozawa, Hong Kyu Lee, Masashi Tanaka. (2007) Mitochondrial Haplogroup N9a Confers Resistance against Type 2 Diabetes in Asians. The American Journal of Human Genetics 80:3, 407-415
CrossRef295
Chris Boesch. (2007) Musculoskeletal spectroscopy. Journal of Magnetic Resonance Imaging 25:2, 321-338
CrossRef296
S. F. E. Praet, H. M. M. De Feyter, R. A. M. Jonkers, K. Nicolay, C. van Pul, H. Kuipers, L. J. C. van Loon, J. J. Prompers. (2007) 31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients. Magnetic Resonance Materials in Physics, Biology and Medicine 19:6, 321-331
CrossRef297
H. Misu, T. Takamura, N. Matsuzawa, A. Shimizu, T. Ota, M. Sakurai, H. Ando, K. Arai, T. Yamashita, M. Honda, T. Yamashita, S. Kaneko. (2007) Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 50:2, 268-277
CrossRef298
Emilie Chanséaume, Anne-Laure Tardy, Jérôme Salles, Christophe Giraudet, Paulette Rousset, Antoine Tissandier, Yves Boirie, Béatrice Morio. (2007) Chronological Approach of Diet-induced Alterations in Muscle Mitochondrial Functions in Rats*. Obesity 15:1, 50-59
CrossRef299
Intekhab Ahmed, Kevin Furlong, Jeremy Flood, Vanita P Treat, Barry J Goldstein. (2007) Dual PPAR ??/?? Agonists: Promises and Pitfalls in Type 2 Diabetes. American Journal of Therapeutics 14:1, 49-62
CrossRef300
Adnan Erol. (2007) The Functions of PPARs in Aging and Longevity. PPAR Research 2007, 1-10
CrossRef301
Hye-Jeong Lee, Mi-Kyoung Park, Kyung Il Lee, Young-Jun An, Ji Min Kim, Ja Young Park, Young Han, Sook-Hee Hong, Sun-Seob Choi, Young Hyun Yoo, Joon Duk Suh, Duk Kyu Kim. (2007) Prevention of Diabetes by Fenofibrate in OLETF Rats: Hepatic Mechanism for Reducing Visceral Adiposity. The Journal of Korean Diabetes Association 31:1, 63
CrossRef302
V. B. Schrauwen-Hinderling, M. E. Kooi, M. K. C. Hesselink, J. A. L. Jeneson, W. H. Backes, C. J. A. Echteld, J. M. A. Engelshoven, M. Mensink, P. Schrauwen. (2006) Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:1, 113-120
CrossRef303
C. Fürnsinn, T. M. Willson, B. Brunmair. (2006) Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport. Diabetologia 50:1, 8-17
CrossRef304
Takeshi Nishikawa, Eiichi Araki. (2006) Impact of Mitochondrial ROS Production in the Pathogenesis of Diabetes Mellitus and Its Complications. Antioxidants & Redox Signaling 0:0, 061221112325010
CrossRef305
Eiichi Araki, Jun-Ichi Miyazaki. (2006) Metabolic Disorders in Diabetes Mellitus: Impact of Mitochondrial Function and Oxidative Stress on Diabetes and Its Complications. Antioxidants & Redox Signaling 0:0, 061221112325005
CrossRef306
Rasmus Rabøl, Robert Boushel, Flemming Dela. (2006) Mitochondrial oxidative function and type 2 diabetes. Applied Physiology, Nutrition, and Metabolism 31:6, 675-683
CrossRef307
Michael H. Davidson, H. Daniel Yannicelli. (2006) New Concepts in Dyslipidemia in the Metabolic Syndrome and Diabetes. Metabolic Syndrome and Related Disorders 4:4, 299-314
CrossRef308
Claudia R. Vianna, Michael Huntgeburth, Roberto Coppari, Cheol Soo Choi, Jiandie Lin, Stefan Krauss, Giorgio Barbatelli, Iphigenia Tzameli, Young-Bum Kim, Saverio Cinti, Gerald I. Shulman, Bruce M. Spiegelman, Bradford B. Lowell. (2006) Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance. Cell Metabolism 4:6, 453-464
CrossRef309
Henrike Sell, Daniela Dietze-Schroeder, Jürgen Eckel. (2006) The adipocyte–myocyte axis in insulin resistance. Trends in Endocrinology & Metabolism 17:10, 416-422
CrossRef310
Marie Lagouge, Carmen Argmann, Zachary Gerhart-Hines, Hamid Meziane, Carles Lerin, Frederic Daussin, Nadia Messadeq, Jill Milne, Philip Lambert, Peter Elliott, Bernard Geny, Markku Laakso, Pere Puigserver, Johan Auwerx. (2006) Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α. Cell 127:6, 1109-1122
CrossRef311
Jolita Ciapaite, Stephan J. L. Bakker, Michaela Diamant, Gerco van Eikenhorst, Robert J. Heine, Hans V. Westerhoff, Klaas Krab. (2006) Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects.. FEBS Journal 273:23, 5288-5302
CrossRef312
Gregory R. Steinberg, Belinda J. Michell, Bryce J.W. van Denderen, Matthew J. Watt, Andrew L. Carey, Barbara C. Fam, Sofianos Andrikopoulos, Joseph Proietto, Cem Z. Görgün, David Carling, Gökhan S. Hotamisligil, Mark A. Febbraio, Thomas W. Kay, Bruce E. Kemp. (2006) Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metabolism 4:6, 465-474
CrossRef313
Anna Wredenberg, Christoph Freyer, Marie E. Sandström, Abram Katz, Rolf Wibom, Håkan Westerblad, Nils-Göran Larsson. (2006) Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochemical and Biophysical Research Communications 350:1, 202-207
CrossRef314
Tomas Fritz, David K. Krämer, Håkan K. R. Karlsson, Dana Galuska, Peter Engfeldt, Juleen R. Zierath, Anna Krook. (2006) Low-intensity exercise increases skeletal muscle protein expression of PPARδ and UCP3 in type 2 diabetic patients. Diabetes/Metabolism Research and Reviews 22:6, 492-498
CrossRef315
Chris Boesch, Juergen Machann, Peter Vermathen, Fritz Schick. (2006) Role of proton MR for the study of muscle lipid metabolism. NMR in Biomedicine 19:7, 968-988
CrossRef316
M. Ryan, A. Sallé, G. Guilloteau, M. Genaitay, M. B. E. Livingstone, P. Ritz. (2006) Resting energy expenditure is not increased in mildly hyperglycaemic obese diabetic patients. British Journal of Nutrition 96:05,
CrossRef317
Jeanine J. Prompers, Jeroen A. L. Jeneson, Maarten R. Drost, Cees C. W. Oomens, Gustav J. Strijkers, Klaas Nicolay. (2006) Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR in Biomedicine 19:7, 927-953
CrossRef318
D. Crispim, N.J.R. Fagundes, L.H. Canani, J.L. Gross, B. Tschiedel, I. Roisenberg. (2006) Role of the mitochondrial m.16189T>C variant in type 2 diabetes mellitus in southern Brazil. Diabetes Research and Clinical Practice 74:2, 204-206
CrossRef319
Torben Østergård, Birgit Nyholm, Troels K. Hansen, Lars M. Rasmussen, Jørgen Ingerslev, Keld E. Sørensen, Hans E. Bøtker, Bengt Saltin, Ole Schmitz. (2006) Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training. Metabolism 55:11, 1508-1515
CrossRef320
Sorel Goland, Sara Shimoni, Taiba Zornitzki, Hilla Knobler, Orly Azoulai, Gaby Lutaty, Ehud Melzer, Ayella Orr, Avraham Caspi, Stephen Malnick. (2006) Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment. Journal of Clinical Gastroenterology 40:10, 949-955
CrossRef321
Stanley Muravchick, Richard J. Levy. (2006) Clinical Implications of Mitochondrial Dysfunction. Anesthesiology 105:4, 819-837
CrossRef322
Simona Kratochvílová, Pavlína Vyhnanovská, Zuzana Vlasáková, Milan Hájek, Jelena Skibová, Terezie Pelikánová. (2006) Metabolic characteristics of soleus muscle in relation to insulin action in the offspring of hypertensive parents. Metabolism 55:10, 1388-1396
CrossRef323
Behzad Molavi, Neda Rasouli, Philip A Kern. (2006) The prevention and treatment of metabolic syndrome and high-risk obesity. Current Opinion in Cardiology 21:5, 479-485
CrossRef324
S. Lindmark, J. Burén, J. W. Eriksson. (2006) Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo. Clinical Endocrinology 65:3, 301-309
CrossRef325
Herbert Tilg, Gökhan S. Hotamisligil. (2006) Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance. Gastroenterology 131:3, 934-945
CrossRef326
J. H. Lim, J. I. Lee, Y. H. Suh, W. Kim, J. H. Song, M. H. Jung. (2006) Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells. Diabetologia 49:8, 1924-1936
CrossRef327
J CAPEAU, C VIGOUROUX, J MAGRE, O LASCOLS, M CARON, J BASTARD. (2006) Les syndromes lipodystrophiques : des adipopathies congénitales ou acquises. Comptes Rendus Biologies 329:8, 639-652
CrossRef328
D. Crispim, L. H. Canani, J. L. Gross, B. Tschiedel, K. E. P. Souto, I. Roisenberg. (2006) The European-Specific Mitochondrial Cluster J/T Could Confer an Increased Risk of Insulin-Resistance and Type 2 Diabetes: An Analysis of the m.4216T > C and m.4917A > G Variants. Annals of Human Genetics 0:0, 060721082338043
CrossRef329
Richa Saxena, Paul I.W. de Bakker, Karyn Singer, Vamsi Mootha, Noël Burtt, Joel N. Hirschhorn, Daniel Gaudet, Bo Isomaa, Mark J. Daly, Leif Groop, Kristin G. Ardlie, David Altshuler. (2006) Comprehensive Association Testing of Common Mitochondrial DNA Variation in Metabolic Disease. The American Journal of Human Genetics 79:1, 54-61
CrossRef330
Anthony E. Civitarese, Barbara Ukropcova, Stacy Carling, Matthew Hulver, Ralph A. DeFronzo, Lawrence Mandarino, Eric Ravussin, Steve R. Smith. (2006) Role of adiponectin in human skeletal muscle bioenergetics. Cell Metabolism 4:1, 75-87
CrossRef331
Xiuli Ci, Frédérique Frisch, François Lavoie, Pascale Germain, Roger Lecomte, Johan E. Lier, François Bénard, André C. Carpentier. (2006) The Effect of Insulin on the Intracellular Distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic Acid in Rats. Molecular Imaging and Biology 8:4, 237-244
CrossRef332
S. Soyal, F. Krempler, H. Oberkofler, W. Patsch. (2006) PGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 49:7, 1477-1488
CrossRef333
W W Hay. (2006) Early postnatal nutritional requirements of the very preterm infant based on a presentation at the NICHD-AAP workshop on research in neonatology. Journal of Perinatology 26, S13-S18
CrossRef334
D. Crispim, L. H. Canani, J. L. Gross, B. Tschiedel, K. E. P. Souto, I. Roisenberg. (2006) The European-Specific Mitochondrial Cluster J/T Could Confer an Increased Risk of Insulin-Resistance and Type 2 Diabetes: An Analysis of the m.4216T > C and m.4917A > G Variants. Annals of Human Genetics 70:4, 488-495
CrossRef335
Joris Hoeks, Matthijs K.C. Hesselink, Patrick Schrauwen. (2006) Involvement of UCP3 in mild uncoupling and lipotoxicity. Experimental Gerontology 41:7, 658-662
CrossRef336
Adrian Chabowski, Jan Górski, Arend Bonen. (2006) Regulation of fatty acid transport: from transcriptional to posttranscriptional effects. Naunyn-Schmiedeberg's Archives of Pharmacology 373:4, 259-263
CrossRef337
Deborah M. Muoio, Christopher B. Newgard. (2006) Obesity-Related Derangements in Metabolic Regulation. Annual Review of Biochemistry 75:1, 367-401
CrossRef338
K. Højlund, J. Frystyk, K. Levin, A. Flyvbjerg, J. F. P. Wojtaszewski, H. Beck-Nielsen. (2006) Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes. Diabetologia 49:6, 1283-1291
CrossRef339
Mark Berneburg. (2006) Oxidativer Stress und Insulinresistenz. Der Hautarzt 57:6, 551-552
CrossRef340
Anna V. Tinker, Alex Boussioutas, David D.L. Bowtell. (2006) The challenges of gene expression microarrays for the study of human cancer. Cancer Cell 9:5, 333-339
CrossRef341
Ram Weiss, Sara E. Taksali, Sonia Caprio. (2006) Development of type 2 diabetes in children and adolescents. Current Diabetes Reports 6:3, 182-187
CrossRef342
Jawahar L. Mehta, Neda Rasouli, Anjan K. Sinha, Behzad Molavi. (2006) Oxidative stress in diabetes: A mechanistic overview of its effects on atherogenesis and myocardial dysfunction. The International Journal of Biochemistry & Cell Biology 38:5-6, 794-803
CrossRef343
Giorgos K. Sakkas, Jane A. Kent-Braun, Julie W. Doyle, Tiffany Shubert, Patricia Gordon, Kirsten L. Johansen. (2006) Effect of Diabetes Mellitus on Muscle Size and Strength in Patients Receiving Dialysis Therapy. American Journal of Kidney Diseases 47:5, 862-869
CrossRef344
Mary C Sugden, Mark J Holness. (2006) Skeletal muscle lipid metabolism and the adipomuscular axis. Future Lipidology 1:2, 153-162
CrossRef345
Patrycja Pawlikowska, Barbara Gajkowska, Jean-Francois Hocquette, Arkadiusz Orzechowski. (2006) Not only insulin stimulates mitochondriogenesis in muscle cells, but mitochondria are also essential for insulin-mediated myogenesis. Cell Proliferation 39:2, 127-145
CrossRef346
H.-J. Choo, J.-H. Kim, O.-B. Kwon, C. S. Lee, J. Y. Mun, S. S. Han, Y.-S. Yoon, G. Yoon, K.-M. Choi, Y.-G. Ko. (2006) Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49:4, 784-791
CrossRef347
Abdullah M.S. Al-Osaimi, Stephen H. Caldwell. (2006) Reply:. Hepatology 43:4, 883-883
CrossRef348
Joan I.A. Campbell, Alicja Mortensen, Per Mølgaard. (2006) Tissue lipid lowering-effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foilage and Citrus aurantium fruit. Journal of Ethnopharmacology 104:3, 379-386
CrossRef349
Kazuaki Nishio, Meiei Shigemitsu, Taro Kusuyama, Tomoyasu Fukui, Kitaro Kawamura, Seiji Itoh, Noburu Konno, Takashi Katagiri. (2006) Insulin resistance in nondiabetic patients with acute myocardial infarction. Cardiovascular Revascularization Medicine 7:2, 54-60
CrossRef350
Rebecca A. Simmons. (2006) Developmental origins of diabetes: The role of oxidative stress. Free Radical Biology and Medicine 40:6, 917-922
CrossRef351
L. E. Fridlyand, L. H. Philipson. (2006) Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes, Obesity and Metabolism 8:2, 136-145
CrossRef352
Vera B. Schrauwen-Hinderling, Matthijs K.C. Hesselink, Patrick Schrauwen, Marianne Eline Kooi. (2006) Intramyocellular Lipid Content in Human Skeletal Muscle*. Obesity 14:3, 357-367
CrossRef353
Philip Kern. 2006. Adipose Tissue Gene Expression in the Context of Inflammation and Obesity. , 83-95.
CrossRef354
Joern W. Helge, Kristian Overgaard, Rasmus Damsgaard, Karsten Sørensen, Jesper L. Andersen, Stig E.U. Dyrskog, Kjeld Hermansen, Bengt Saltin, Jørgen F.P. Wojtaszewski. (2006) Repeated prolonged whole-body low-intensity exercise: effects on insulin sensitivity and limb muscle adaptations. Metabolism 55:2, 217-223
CrossRef355
Geoffrey C. Farrell, Claire Z. Larter. (2006) Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 43:S1, S99-S112
CrossRef356
Neil B. Ruderman, Asish K. Saha. (2006) Metabolic Syndrome: Adenosine Monophosphate-activated Protein Kinase and Malonyl Coenzyme A. Obesity 14:2S, 25S-33S
CrossRef357
Kitt Falk Petersen, Gerald I. Shulman. (2006) New Insights into the Pathogenesis of Insulin Resistance in Humans Using Magnetic Resonance Spectroscopy. Obesity 14:2S, 34S-40S
CrossRef358
Luc J.C. Loon, Bret H. Goodpaster. (2006) Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflügers Archiv - European Journal of Physiology 451:5, 606-616
CrossRef359
C. Rattarasarn. (2006) Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes. Acta Physiologica 186:2, 87-101
CrossRef360
Marilyn Valentine, Elliot Rayfield. 2006. Pathophysiology and Clinical Management of Diabetes and Prediabetes. , 15-44.
CrossRef361
Kevin Short. 2006. Muscle Atrophy During Aging. , 305-335.
CrossRef362
Johan Auwerx. (2006) Improving metabolism by increasing energy expenditure. Nature Medicine 12:1, 44-45
CrossRef363
Richard J. Levy, Stanley Muravchick. 2006. Mitochondrial Diseases. , 455-467.
CrossRef364
Hyo-Jung Choo, Young-Gyu Ko. (2006) Type 2 Diabetes and Mitochondria. Journal of Korean Endocrine Society 21:4, 266
CrossRef365
Carlos Bernal-Mizrachi, Clay F Semenkovich. (2006) Fast predators or fast food, the fit still survive. Nature Medicine 12:1, 46-47
CrossRef366
James B Meigs. (2006) Metabolic syndrome and risk for Type 2 diabetes. Expert Review of Endocrinology & Metabolism 1:1, 57-66
CrossRef367
Ravi Nistala, Craig S. Stump. (2006) Skeletal Muscle Insulin Resistance Is Fundamental to the Cardiometabolic Syndrome. Journal of the CardioMetabolic Syndrome 1:1, 47-52
CrossRef368
Dragan Micic. (2006) Insulin resistance and atherosclerosis. Jugoslovenska medicinska biohemija 25:4, 343-348
CrossRef369
J. G. Leichman, V. R. Lavis, D. Aguilar, C. R. Wilson, H. Taegtmeyer. (2006) The metabolic syndrome and the heart—. Clinical Research in Cardiology 95:S1, i134-i141
CrossRef370
EH Cho, EH Koh, MS Kim, JY Park, KU Lee. (2006) Mitochondrial Dysfunction and Insulin Resistance. The Journal of Korean Diabetes Association 30:6, 409
CrossRef371
David S H Bell. (2006) The Case for Combination Therapy as First-Line Treatment for the Type 2 Diabetic Patient. Treatments in Endocrinology 5:3, 131-137
CrossRef372
Anabela P. Rolo, Carlos M. Palmeira. (2006) Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicology and Applied Pharmacology 212:2, 167
CrossRef373
James A. Timmons, Jessica Norrbom, Camilla Schéele, Håkan Thonberg, Claes Wahlestedt, Per Tesch. (2006) Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes. Genomics 87:1, 165-172
CrossRef374
J. Hoeks, M. K. C. Hesselink, A. P. Russell, M. Mensink, W. H. M. Saris, R. P. Mensink, P. Schrauwen. (2006) Peroxisome proliferator-activated receptor-γ coactivator-1 and insulin resistance: acute effect of fatty acids. Diabetologia 49:10, 2419
CrossRef375
D. Crispim, L. H. Canani, J. L. Gross, R. M. Carlessi, B. Tschiedel, K. E. P. Souto, I. Roisenberg. (2005) The G1888A variant in the mitochondrial 16S rRNA gene may be associated with Type 2 diabetes in Caucasian-Brazilian patients from southern Brazil. Diabetic Medicine 22:12, 1683-1689
CrossRef376
A. Golay, J. Ybarra. (2005) Link between obesity and type 2 diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 19:4, 649-663
CrossRef377
P. Ritz, G. Berrut. (2005) Mitochondrial function, energy expenditure, aging and insulin resistance. Diabetes & Metabolism 31, 5S67-5S73
CrossRef378
Douglas C. Wallace. (2005) A MITOCHONDRIAL PARADIGM OF METABOLIC AND DEGENERATIVE DISEASES, AGING, AND CANCER: A Dawn for Evolutionary Medicine. Annual Review of Genetics 39:1, 359-407
CrossRef379
Michael Freemark. 2005. Type 2 Diabetes in Childhood. , 177-204.
CrossRef380
John Thyfault, G Lynis Dohm. 2005. Metabolic Alterations in Muscle Associated with Obesity. , 79-98.
CrossRef381
David S. Heppner, Stephen A. Harrison. (2005) Obesity, insulin resistance, and HCV: Implications for pathogenesis. Current Hepatitis Reports 4:4, 153-157
CrossRef382
J. C. Lo, M. R. Kazemi, P. Y. Hsue, J. N. Martin, S. G. Deeks, M. Schambelan, K. Mulligan. (2005) The Relationship between Nucleoside Analogue Treatment Duration, Insulin Resistance, and Fasting Arterialized Lactate Level in Patients with HIV Infection. Clinical Infectious Diseases 41:9, 1335-1340
CrossRef383
Karen L. Mohlke, Anne U. Jackson, Laura J. Scott, Erin C. Peck, Yong D. Suh, Peter S. Chines, Richard M. Watanabe, Thomas A. Buchanan, Karen N. Conneely, Michael R. Erdos, Narisu Narisu, Sareena Enloe, Timo T. Valle, Jaakko Tuomilehto, Richard N. Bergman, Michael Boehnke, Francis S. Collins. (2005) Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Human Genetics 118:2, 245-254
CrossRef384
M. Krebs, M. Roden. (2005) Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes, Obesity and Metabolism 7:6, 621-632
CrossRef385
Jonas Burén, Jan W. Eriksson. (2005) Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?. Diabetes/Metabolism Research and Reviews 21:6, 487-494
CrossRef386
Y. M. Cho, H. D. Shin, B. L. Park, J. H. Kim, K. S. Park, S. Y. Kim, H. K. Lee. (2005) Association between polymorphisms in the nuclear respiratory factor 1 gene and type 2 diabetes mellitus in the Korean population. Diabetologia 48:10, 2033-2038
CrossRef387
Ellen E. Blaak. (2005) Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance. Best Practice & Research Clinical Endocrinology & Metabolism 19:3, 391-403
CrossRef388
M. A. Zulet, A. Marti, M. D. Parra, J. A. Martínez. (2005) Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health. Journal of Physiology and Biochemistry 61:3, 483-494
CrossRef389
M Roden. (2005) Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. International Journal of Obesity 29, S111-S115
CrossRef390
F Guerrero-Romero, M Rodríguez-Morán, M González-Ortiz, E Martínez-Abundis. (2005) Early decrease of the percent of HOMA ɛ-cell function is independently related to family history of diabetes in healthy young nonobese individuals. Diabetes & Metabolism 31:4, 382-386
CrossRef391
Rafal M. Smigrodzki, Shaharyar M. Khan. (2005) Mitochondrial Microheteroplasmy and a Theory of Aging and Age-Related Disease. Rejuvenation Research 8:3, 172-198
CrossRef392
Ram Weiss, Sonia Caprio. (2005) The metabolic consequences of childhood obesity. Best Practice & Research Clinical Endocrinology & Metabolism 19:3, 405-419
CrossRef393
Evelyn Artz, Andrea Haqq, Michael Freemark. (2005) Hormonal and Metabolic Consequences of Childhood Obesity. Endocrinology & Metabolism Clinics of North America 34:3, 643-658
CrossRef394
Faidon Magkos, Labros S Sidossis. (2005) Methodological approaches to the study of metabolism across individual tissues in man. Current Opinion in Clinical Nutrition and Metabolic Care 8:5, 501-510
CrossRef395
Steven G. Gray, Pierre De Meyts. (2005) Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes/Metabolism Research and Reviews 21:5, 416-433
CrossRef396
Lore Metz, Pascal Sirvent, Guillaume Py, Jean-Frederic Brun, Christine Fédou, Eric Raynaud, Jacques Mercier. (2005) Relationship between blood lactate concentration and substrate utilization during exercise in type 2 diabetic postmenopausal women. Metabolism 54:8, 1102-1107
CrossRef397
Jenny E. Gunton, Rohit N. Kulkarni, SunHee Yim, Terumasa Okada, Wayne J. Hawthorne, Yu-Hua Tseng, Russell S. Roberson, Camillo Ricordi, Philip J. O’Connell, Frank J. Gonzalez, C. Ronald Kahn. (2005) Loss of ARNT/HIF1β Mediates Altered Gene Expression and Pancreatic-Islet Dysfunction in Human Type 2 Diabetes. Cell 122:3, 337-349
CrossRef398
Gianluca Perseghin. (2005) Muscle lipid metabolism in the metabolic syndrome. Current Opinion in Lipidology 16:4, 416-420
CrossRef399
David S. H. Bell. (2005) Optimizing treatment of diabetes and cardiovascular disease with combined α,β‐blockade. Current Medical Research and Opinion 21:8, 1191-1200
CrossRef400
Yves Boisclair, Michel L. Tremblay. (2005) Firing up Mitochondrial Activities with PTPMT1. Molecular Cell 19:3, 291-292
CrossRef401
David A DʼAlessio, Kim-Anne Lê, Luc Tappy. (2005) Type 2 diabetes and insulin resistance: an hepatocentric phenomenon?. Current Opinion in Clinical Nutrition and Metabolic Care 8:4, 428-430
CrossRef402
Woo Je Lee, Kee-Ho Song, Eun Hee Koh, Jong Chul Won, Hyoun Sik Kim, Hye-Sun Park, Min-Seon Kim, Seung-Whan Kim, Ki-Up Lee, Joong-Yeol Park. (2005) α-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochemical and Biophysical Research Communications 332:3, 885-891
CrossRef403
Patrick Ritz, Jean-François Dumas, Pierre-Henri Ducluzeau, Gilles Simard. (2005) Hormonal regulation of mitochondrial energy production. Current Opinion in Clinical Nutrition and Metabolic Care 8:4, 415-418
CrossRef404
R. L. Kennedy, K. Chokkalingam, H. R. Farshchi. (2005) Nutrition in patients with Type 2 diabetes: are low-carbohydrate diets effective, safe or desirable?. Diabetic Medicine 22:7, 821-832
CrossRef405
Susanne Neschen, Katsutaro Morino, Linda E. Hammond, Dongyan Zhang, Zhen-Xiang Liu, Anthony J. Romanelli, Gary W. Cline, Rebecca L. Pongratz, Xian-Man Zhang, Cheol S. Choi, Rosalind A. Coleman, Gerald I. Shulman. (2005) Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metabolism 2:1, 55-65
CrossRef406
Ivan Tkáč. (2005) Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Research and Clinical Practice 68, S2-S9
CrossRef407
H. Kolb, T. Mandrup-Poulsen. (2005) An immune origin of type 2 diabetes?. Diabetologia 48:6, 1038-1050
CrossRef408
Gary V Desir. (2005) Kv1.3 potassium channel blockade as an approach to insulin resistance. Expert Opinion on Therapeutic Targets 9:3, 571-579
CrossRef409
Rebecca Parish, Kitt Falk Petersen. (2005) Mitochondrial dysfunction and type 2 diabetes. Current Diabetes Reports 5:3, 177-183
CrossRef410
HONG KYU LEE, KYONG SOO PARK, YOUNG MIN CHO, YUN YONG LEE, YOUNGMI KIM PAK. (2005) Mitochondria-Based Model for Fetal Origin of Adult Disease and Insulin Resistance. Annals of the New York Academy of Sciences 1042:1, 1-18
CrossRef411
TSU-KUNG LIN, SHANG-DER CHEN, PEI-WEN WANG, YAU-HUEI WEI, CHENG-FENG LEE, TZU-LING CHEN, YAO-CHUNG CHUANG, TENG-YEOW TAN, KU-CHOU CHANG, CHIA-WEI LIOU. (2005) Increased Oxidative Damage with Altered Antioxidative Status in Type 2 Diabetic Patients Harboring the 16189 T to C Variant of Mitochondrial DNA. Annals of the New York Academy of Sciences 1042:1, 64-69
CrossRef412
J LEAHY. (2005) Pathogenesis of Type 2 Diabetes Mellitus. Archives of Medical Research 36:3, 197-209
CrossRef413
Abdullah M. S. Al-Osaimi, Carl L Berg, Stephen H. Caldwell. (2005) Intermittent disconjugate gaze: A novel finding in nonalcoholic steatohepatitis and cryptogenic cirrhosis. Hepatology 41:4, 943-943
CrossRef414
Michael Stumvoll, Barry J Goldstein, Timon W van Haeften. (2005) Type 2 diabetes: principles of pathogenesis and therapy. The Lancet 365:9467, 1333-1346
CrossRef415
Robert H Eckel, Scott M Grundy, Paul Z Zimmet. (2005) The metabolic syndrome. The Lancet 365:9468, 1415-1428
CrossRef416
G. Lattuada, F. Costantino, A. Caumo, P. Scifo, F. Ragogna, F. Cobelli, A. Maschio, L. Luzi, G. Perseghin. (2005) Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients. Diabetologia 48:4, 741-747
CrossRef417
Edward D. Javor, Marc G. Ghany, Elaine K. Cochran, Elif Arioglu Oral, Alex M. DePaoli, Ahalya Premkumar, David E. Kleiner, Phillip Gorden. (2005) Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Hepatology 41:4, 753-760
CrossRef418
Frederico G.S Toledo, David E Kelley. (2005) Mitochondrial dysfunction in the pathogenesis of insulin resistance associated with obesity, diabetes, and aging. Current Opinion in Endocrinology & Diabetes 12:2, 157-162
CrossRef419
Nina Vasavada, Rajiv Agarwal. (2005) Role of oxidative stress in diabetic nephropathy. Advances in Chronic Kidney Disease 12:2, 146-154
CrossRef420
Suresh Mishra, Leigh C. Murphy, B.L. Gregoire Nyomba, Liam J. Murphy. (2005) Prohibitin: a potential target for new therapeutics. Trends in Molecular Medicine 11:4, 192-197
CrossRef421
Marie-Luise Gross, Ralf Dikow, Eberhard Ritz. (2005) Diabetic nephropathy: Recent insights into the pathophysiology and the progression of diabetic nephropathy. Kidney International 67:s94, s50-s53
CrossRef422
Ehab Farag, Glenn DeBoer, Bruce H. Cohen, Julie Niezgoda. (2005) Metabolic Acidosis due to Propofol Infusion. Anesthesiology 102:3, 697-698
CrossRef423
Melek C Arkan, Andrea L Hevener, Florian R Greten, Shin Maeda, Zhi-Wei Li, Jeffrey M Long, Anthony Wynshaw-Boris, Giuseppe Poli, Jerrold Olefsky, Michael Karin. (2005) IKK-β links inflammation to obesity-induced insulin resistance. Nature Medicine 11:2, 191-198
CrossRef424
A. Kriketos, K.-L. Milner, G. Denyer, L. Campbell. (2005) Is postprandial hypertriglyceridaemia in relatives of type 2 diabetic subjects a consequence of insulin resistance?. European Journal of Clinical Investigation 35:2, 117-125
CrossRef425
Mario Chojkier. (2005) Troglitazone and liver injury: In search of answers. Hepatology 41:2, 237-246
CrossRef426
V. Aas, M. Rokling-Andersen, A. J. Wensaas, G. H. Thoresen, E. T. Kase, A. C. Rustan. (2005) Lipid metabolism in human skeletal muscle cells: effects of palmitate and chronic hyperglycaemia. Acta Physiologica Scandinavica 183:1, 31-41
CrossRef427
Teresa C. Leone, John J. Lehman, Brian N. Finck, Paul J. Schaeffer, Adam R. Wende, Sihem Boudina, Michael Courtois, David F. Wozniak, Nandakumar Sambandam, Carlos Bernal-Mizrachi, Zhouji Chen, John O. Holloszy, Denis M. Medeiros, Robert E. Schmidt, Jeffrey E. Saffitz, E. Dale Abel, Clay F. Semenkovich, Daniel P. Kelly. (2005) PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis. PLoS Biology 3:4, e101
CrossRef428
Anton J. M. Wagenmakers. (2005) Insulin Resistance in the Offspring of Parents with Type 2 Diabetes. PLoS Medicine 2:9, e289
CrossRef429
Kitt F. Petersen, Sylvie Dufour, Gerald I. Shulman. (2005) Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents. PLoS Medicine 2:9, e233
CrossRef430
Abu R. Vasudevan, Ashok Balasubramanyam. (2004) Thiazolidinediones: A Review of Their Mechanisms of Insulin Sensitization, Therapeutic Potential, Clinical Efficacy, and Tolerability. Diabetes Technology & Therapeutics 6:6, 850-863
CrossRef431
Bret H Goodpaster, Donna Wolf. (2004) Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatric Diabetes 5:4, 219-226
CrossRef432
A. Hamann, M. Morcos, P. Nawroth. (2004) Orale Diabetestherapie. Der Internist 45:12, 1356-1363
CrossRef433
Alan R. Shuldiner, John C. McLenithan. (2004) Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again. Journal of Clinical Investigation 114:10, 1414-1417
CrossRef434
Juan C. Molero, Thomas E. Jensen, Phil C. Withers, Michelle Couzens, Herbert Herzog, Christine B.F. Thien, Wallace Y. Langdon, Ken Walder, Maria A. Murphy, David D.L. Bowtell, David E. James, Gregory J. Cooney. (2004) c-Cbl–deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. Journal of Clinical Investigation 114:9, 1326-1333
CrossRef435
Joseph L. Evans, Jack F. Youngren, Ira D. Goldfine. (2004) Effective treatments for insulin resistance: trim the fat and douse the fire. Trends in Endocrinology & Metabolism 15:9, 425-431
CrossRef436
Sander M. Houten, Johan Auwerx. (2004) PGC-1α. Cell 119:1, 5-7
CrossRef437
F. Civeira Murillo, E. Meriño-Ibarra, J. Mozota Duarte, J.A. Pinilla López-Oliva. (2004) Síndrome metabólico. Medicine - Programa de Formación Médica Continuada Acreditado 9:18, 1131-1139
CrossRef438
Sivaram Pillarisetti, Uday Saxena. (2004) Role of oxidative stress and inflammation in the origin of Type 2 diabetes – a paradigm shift. Expert Opinion on Therapeutic Targets 8:5, 401-408
CrossRef439
Jiandie Lin, Pei-Hsuan Wu, Paul T. Tarr, Katrin S. Lindenberg, Julie St-Pierre, Chen-yu Zhang, Vamsi K. Mootha, Sibylle Jäger, Claudia R. Vianna, Richard M. Reznick, Libin Cui, Monia Manieri, Mi X. Donovan, Zhidan Wu, Marcus P. Cooper, Melina C. Fan, Lindsay M. Rohas, Ann Marie Zavacki, Saverio Cinti, Gerald I. Shulman, Bradford B. Lowell, Dimitri Krainc, Bruce M. Spiegelman. (2004) Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice. Cell 119:1, 121-135
CrossRef440
B. Brunmair, F. Gras, L. Wagner, M. Artwohl, B. Zierhut, W. Waldh
usl, C. F
CrossRef441
David S. H. Bell. (2004) Management of Type 2 Diabetes With Thiazolidinediones. The Endocrinologist 14:5, 293-299
CrossRef442
Bruce A. Barshop, Robert K. Naviaux, Karen A. McGowan, Fred Levine, William L. Nyhan, Amalia Loupis-Geller, Richard H. Haas. (2004) Chronic treatment of mitochondrial disease patients with dichloroacetate. Molecular Genetics and Metabolism 83:1-2, 138-149
CrossRef443
Martie Truschnig-Wilders, Bernhard O. Boehm, Winfried März. (2004) Laboratoriumsdiagnostik bei Diabetes mellitus/Laboratory diagnostics in patients with diabetes mellitus. LaboratoriumsMedizin 28:4, 334-345
CrossRef444
Pamela Dalton, Alan Gelperin, George Preti. (2004) Volatile Metabolic Monitoring of Glycemic Status in Diabetes Using Electronic Olfaction. Diabetes Technology & Therapeutics 6:4, 534-544
CrossRef445
Meghan Kelly, Charlotte Keller, Paco R. Avilucea, Pernille Keller, Zhijun Luo, Xiaoquin Xiang, Mercé Giralt, Juan Hidalgo, Asish K. Saha, Bente K. Pedersen, Neil B. Ruderman. (2004) AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochemical and Biophysical Research Communications 320:2, 449-454
CrossRef446
Mary-Elizabeth Patti. (2004) Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology?. Current Opinion in Clinical Nutrition and Metabolic Care 7:4, 383-390
CrossRef447
Roberto Scatena, Patrizia Bottoni, Giuseppe Ettore Martorana, Franco Ferrari, Pasquale De Sole, Cristina Rossi, Bruno Giardina. (2004) Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: biochemical and pharmacological implications. Biochemical and Biophysical Research Communications 319:3, 967-973
CrossRef448
(2004) Impaired Mitochondrial Activity and Insulin-Resistant Offspring of Patients with Type 2 Diabetes. New England Journal of Medicine 350:23, 2419-2421
Full Text449
Vicki Brower. (2004) Like a snake in the grass. EMBO reports 5:6, 555-558
CrossRef450
Mary-Elizabeth Patti. (2004) Gene expression in the pathophysiology of type 2 diabetes mellitus. Current Diabetes Reports 4:3, 176-181
CrossRef451
Ulrich Keller. (2004) Zukunftsperspektiven in der Therapie des Typ-2-Diabetes. Wiener Klinische Wochenschrift 116:7-8, 213-214
CrossRef452
Douglas B. Coursin, Lisa E. Connery, Jonathan T. Ketzler. (2004) Perioperative diabetic and hyperglycemic management issues. Critical Care Medicine 32:Supplement, S116-S125
CrossRef453
Taylor, Roy, . (2004) Causation of Type 2 Diabetes — The Gordian Knot Unravels. New England Journal of Medicine 350:7, 639-641
Full Text454
Juleen R. Zierath, John A. Hawley. (2004) Skeletal Muscle Fiber Type: Influence on Contractile and Metabolic Properties. PLoS Biology 2:10, e348
CrossRef
- Letters
